| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | MYCBP2 MCF2L2 OBSCN BCR HERC2 KALRN ARHGEF5 DOCK10 DIS3 CCDC88C EEF1B2 ARHGEF40 ITSN2 | 1.74e-05 | 231 | 271 | 13 | GO:0005085 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | AARS1 DDX59 POLA2 GGT3P DHX15 APEX2 DQX1 EXOSC6 MLH1 DSCC1 TARS1 DNMT3A RAD51D TRMT9B DDX12P TUT7 CHD9 DIS3 GGT2P NSUN3 FBH1 CHTF18 SNRNP200 | 2.59e-05 | 645 | 271 | 23 | GO:0140640 |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 8.74e-05 | 18 | 271 | 4 | GO:0004016 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity | 1.84e-04 | 2 | 271 | 2 | GO:0016316 | |
| GeneOntologyMolecularFunction | inositol-3,4-bisphosphate 4-phosphatase activity | 1.84e-04 | 2 | 271 | 2 | GO:0052828 | |
| GeneOntologyMolecularFunction | inositol-1,3,4-trisphosphate 4-phosphatase activity | 1.84e-04 | 2 | 271 | 2 | GO:0017161 | |
| GeneOntologyMolecularFunction | cyclase activity | 2.85e-04 | 24 | 271 | 4 | GO:0009975 | |
| GeneOntologyMolecularFunction | helicase activity | 3.16e-04 | 158 | 271 | 9 | GO:0004386 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 3.35e-04 | 25 | 271 | 4 | GO:0016849 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase (NADP+) activity | 5.46e-04 | 3 | 271 | 2 | GO:0033721 | |
| HumanPheno | Linear nevus sebaceous | 5.52e-06 | 3 | 91 | 3 | HP:0010817 | |
| Domain | Ank_2 | TANC2 TRPC6 ANKRD30B ANKRD20A2P ANKRD20A3P KIDINS220 ANKRD20A4P ASB8 ANKRD18A HECTD1 ANKRD20A1 ANKRD35 TRPC7 ASB13 ANKRD30A ANKRD24 | 1.01e-07 | 215 | 270 | 16 | PF12796 |
| Domain | NFAT | 2.11e-07 | 5 | 270 | 4 | IPR008366 | |
| Domain | Ank | TANC2 TRPC6 ANKRD30B ANKRD20A2P ANKRD20A3P KIDINS220 ANKRD20A4P ASB8 ANKRD18A HECTD1 ANKRD20A1 ANKRD35 TRPC7 ASB13 ANKRD30A ANKRD24 | 2.25e-07 | 228 | 270 | 16 | PF00023 |
| Domain | - | TANC2 TRPC6 ANKRD30B ANKRD20A2P ANKRD20A3P KIDINS220 ANKRD20A4P ASB8 ANKRD18A HECTD1 ANKRD20A1 ANKRD35 TRPC7 ASB13 ANKRD30A ANKRD24 | 6.98e-07 | 248 | 270 | 16 | 1.25.40.20 |
| Domain | ANK | TANC2 TRPC6 ANKRD30B ANKRD20A2P ANKRD20A3P KIDINS220 ANKRD20A4P ASB8 ANKRD18A HECTD1 ANKRD20A1 ANKRD35 TRPC7 ASB13 ANKRD30A ANKRD24 | 8.19e-07 | 251 | 270 | 16 | SM00248 |
| Domain | ANK_REPEAT | TANC2 TRPC6 ANKRD30B ANKRD20A2P ANKRD20A3P KIDINS220 ANKRD20A4P ASB8 ANKRD18A HECTD1 ANKRD20A1 ANKRD35 TRPC7 ASB13 ANKRD30A ANKRD24 | 9.10e-07 | 253 | 270 | 16 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | TANC2 TRPC6 ANKRD30B ANKRD20A2P ANKRD20A3P KIDINS220 ANKRD20A4P ASB8 ANKRD18A HECTD1 ANKRD20A1 ANKRD35 TRPC7 ASB13 ANKRD30A ANKRD24 | 9.58e-07 | 254 | 270 | 16 | IPR020683 |
| Domain | ANK_REP_REGION | TANC2 TRPC6 ANKRD30B ANKRD20A2P ANKRD20A3P KIDINS220 ANKRD20A4P ASB8 ANKRD18A HECTD1 ANKRD20A1 ANKRD35 TRPC7 ASB13 ANKRD30A ANKRD24 | 9.58e-07 | 254 | 270 | 16 | PS50297 |
| Domain | Ankyrin_rpt | TANC2 TRPC6 ANKRD30B ANKRD20A2P ANKRD20A3P KIDINS220 ANKRD20A4P ASB8 ANKRD18A HECTD1 ANKRD20A1 ANKRD35 TRPC7 ASB13 ANKRD30A ANKRD24 | 1.44e-06 | 262 | 270 | 16 | IPR002110 |
| Domain | - | DDX59 RNF112 RAB22A PSMC2 SMC5 DHX15 DQX1 HRAS IFI44L ABCD2 RAB4A NLRP13 RAB12 RAD51D KRAS NRAS RAB3D ABCB6 CHD9 AK8 URGCP SBNO2 NLRP9 FBH1 CHTF18 COASY SNRNP200 HYDIN | 4.09e-06 | 746 | 270 | 28 | 3.40.50.300 |
| Domain | P-loop_NTPase | TANC2 DDX59 RNF112 RAB22A PSMC2 SMC5 DHX15 DQX1 HRAS IFI44L MYO18B ABCD2 RAB4A NLRP13 RAB12 RAD51D KRAS NRAS RAB3D ABCB6 CHD9 AK8 URGCP SBNO2 NLRP9 FBH1 CHTF18 COASY SNRNP200 HYDIN | 5.90e-06 | 848 | 270 | 30 | IPR027417 |
| Domain | RHD_dimer | 8.38e-06 | 10 | 270 | 4 | PF16179 | |
| Domain | REL_1 | 8.38e-06 | 10 | 270 | 4 | PS01204 | |
| Domain | NFkB/Dor | 8.38e-06 | 10 | 270 | 4 | IPR000451 | |
| Domain | RHD_DNA_bind_dom | 8.38e-06 | 10 | 270 | 4 | IPR011539 | |
| Domain | RHD_dimer | 8.38e-06 | 10 | 270 | 4 | IPR032397 | |
| Domain | - | 8.38e-06 | 10 | 270 | 4 | 2.60.40.340 | |
| Domain | RHD_DNA_bind | 8.38e-06 | 10 | 270 | 4 | PF00554 | |
| Domain | REL_2 | 8.38e-06 | 10 | 270 | 4 | PS50254 | |
| Domain | Adcy_conserved_dom | 5.79e-05 | 6 | 270 | 3 | IPR009398 | |
| Domain | DUF1053 | 5.79e-05 | 6 | 270 | 3 | PF06327 | |
| Domain | RhoGEF | 6.73e-05 | 70 | 270 | 7 | PF00621 | |
| Domain | DH_2 | 6.73e-05 | 70 | 270 | 7 | PS50010 | |
| Domain | - | 7.37e-05 | 71 | 270 | 7 | 1.20.900.10 | |
| Domain | DH-domain | 7.37e-05 | 71 | 270 | 7 | IPR000219 | |
| Domain | A/G_cyclase_CS | 8.76e-05 | 17 | 270 | 4 | IPR018297 | |
| Domain | Vinculin/catenin | 1.00e-04 | 7 | 270 | 3 | IPR006077 | |
| Domain | Nucleotide_cyclase | 1.11e-04 | 18 | 270 | 4 | IPR029787 | |
| Domain | - | 1.11e-04 | 18 | 270 | 4 | 3.30.70.1230 | |
| Domain | Guanylate_cyc | 1.40e-04 | 19 | 270 | 4 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 1.40e-04 | 19 | 270 | 4 | PS50125 | |
| Domain | A/G_cyclase | 1.40e-04 | 19 | 270 | 4 | IPR001054 | |
| Domain | CYCc | 1.40e-04 | 19 | 270 | 4 | SM00044 | |
| Domain | GUANYLATE_CYCLASE_1 | 1.40e-04 | 19 | 270 | 4 | PS00452 | |
| Domain | AC_N | 1.59e-04 | 8 | 270 | 3 | IPR032628 | |
| Domain | AC_N | 1.59e-04 | 8 | 270 | 3 | PF16214 | |
| Domain | Adcy | 1.59e-04 | 8 | 270 | 3 | IPR030672 | |
| Domain | ARHGEF5_35 | 2.08e-04 | 2 | 270 | 2 | PF15441 | |
| Domain | ARHGEF5/35_N | 2.08e-04 | 2 | 270 | 2 | IPR029212 | |
| Domain | DH_1 | 2.94e-04 | 63 | 270 | 6 | PS00741 | |
| Domain | - | ATR ARMC3 PIK3R4 AP5Z1 HECTD1 GCN1 TANGO6 CIP2A HEATR1 MTOR CTNNB1 | 4.03e-04 | 222 | 270 | 11 | 1.25.10.10 |
| Domain | ARM-type_fold | ATR ARMC3 ITPR2 PIK3R4 URB1 DIAPH2 HECTD1 GCN1 TANGO6 CIP2A HEATR1 PPP2R5B MTOR CTNNB1 | 4.42e-04 | 339 | 270 | 14 | IPR016024 |
| Domain | RhoGEF | 4.46e-04 | 68 | 270 | 6 | SM00325 | |
| Domain | Ig_I-set | PDGFRB SPEG OBSCN IGSF22 HMCN2 NRCAM KALRN UNC5C MUSK MYBPC2 | 4.59e-04 | 190 | 270 | 10 | IPR013098 |
| Domain | I-set | PDGFRB SPEG OBSCN IGSF22 HMCN2 NRCAM KALRN UNC5C MUSK MYBPC2 | 4.59e-04 | 190 | 270 | 10 | PF07679 |
| Domain | HEAT_REPEAT | 5.22e-04 | 70 | 270 | 6 | PS50077 | |
| Domain | IPT | 5.77e-04 | 27 | 270 | 4 | SM00429 | |
| Domain | ARM-like | ATR ARMC3 PIK3R4 AP5Z1 HECTD1 GCN1 TANGO6 CIP2A DOCK10 HEATR1 MTOR CTNNB1 | 5.91e-04 | 270 | 270 | 12 | IPR011989 |
| Domain | D-isomer_DH_CS1 | 6.19e-04 | 3 | 270 | 2 | IPR029752 | |
| Domain | FYVE | 7.63e-04 | 29 | 270 | 4 | SM00064 | |
| Domain | FYVE | 7.63e-04 | 29 | 270 | 4 | PF01363 | |
| Domain | TIG | 9.88e-04 | 31 | 270 | 4 | PF01833 | |
| Domain | SPEC | 1.12e-03 | 32 | 270 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.12e-03 | 32 | 270 | 4 | IPR018159 | |
| Domain | IPT | 1.12e-03 | 32 | 270 | 4 | IPR002909 | |
| Domain | PI3/4_kinase_CS | 1.20e-03 | 15 | 270 | 3 | IPR018936 | |
| Domain | MIB_HERC2 | 1.23e-03 | 4 | 270 | 2 | PS51416 | |
| Domain | MIB_HERC2 | 1.23e-03 | 4 | 270 | 2 | PF06701 | |
| Domain | Alpha_catenin | 1.23e-03 | 4 | 270 | 2 | IPR001033 | |
| Domain | VINCULIN_1 | 1.23e-03 | 4 | 270 | 2 | PS00663 | |
| Domain | Mib_Herc2 | 1.23e-03 | 4 | 270 | 2 | IPR010606 | |
| Domain | Vinculin_CS | 1.23e-03 | 4 | 270 | 2 | IPR000633 | |
| Domain | Znf_FYVE-rel | 1.41e-03 | 34 | 270 | 4 | IPR017455 | |
| Domain | PI3Kc | 1.46e-03 | 16 | 270 | 3 | SM00146 | |
| Domain | - | 1.46e-03 | 16 | 270 | 3 | 1.10.1070.11 | |
| Domain | HEAT | 1.49e-03 | 58 | 270 | 5 | IPR000357 | |
| Domain | HEAT_type_2 | 1.75e-03 | 17 | 270 | 3 | IPR021133 | |
| Domain | Vinculin | 2.02e-03 | 5 | 270 | 2 | PF01044 | |
| Domain | PFTB_repeat | 2.02e-03 | 5 | 270 | 2 | IPR001330 | |
| Domain | D-isomer_DH_NAD-bd | 2.02e-03 | 5 | 270 | 2 | IPR006140 | |
| Domain | Prenyltrans | 2.02e-03 | 5 | 270 | 2 | PF00432 | |
| Domain | FATC | 2.02e-03 | 5 | 270 | 2 | PF02260 | |
| Domain | PI3/4_kinase_cat_dom | 2.08e-03 | 18 | 270 | 3 | IPR000403 | |
| Domain | PI3_PI4_kinase | 2.08e-03 | 18 | 270 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 2.08e-03 | 18 | 270 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.08e-03 | 18 | 270 | 3 | PS00916 | |
| Domain | PI3_4_KINASE_3 | 2.08e-03 | 18 | 270 | 3 | PS50290 | |
| Domain | Znf_FYVE | 2.14e-03 | 38 | 270 | 4 | IPR000306 | |
| Domain | IGc2 | PDGFRB SPEG OBSCN IGSF22 HMCN2 NRCAM KALRN UNC5C MUSK MYBPC2 | 2.29e-03 | 235 | 270 | 10 | SM00408 |
| Domain | Ig_sub2 | PDGFRB SPEG OBSCN IGSF22 HMCN2 NRCAM KALRN UNC5C MUSK MYBPC2 | 2.29e-03 | 235 | 270 | 10 | IPR003598 |
| Domain | Kinase-like_dom | ATR PDGFRB SPEG OBSCN PIK3R4 DST MAST4 PI4KB FGR TLK2 NPR2 KALRN CHD9 MTOR IKBKB LYN MUSK | 2.40e-03 | 542 | 270 | 17 | IPR011009 |
| Pathway | KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY | 1.39e-06 | 75 | 206 | 9 | M5436 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 4.24e-06 | 46 | 206 | 7 | M39828 | |
| Pathway | KEGG_ENDOMETRIAL_CANCER | 9.85e-06 | 52 | 206 | 7 | M19877 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 1.35e-05 | 11 | 206 | 4 | M29814 | |
| Pathway | REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS | 3.01e-05 | 5 | 206 | 3 | M26921 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 3.93e-05 | 140 | 206 | 10 | M27484 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS | 3.95e-05 | 14 | 206 | 4 | M27908 | |
| Pathway | KEGG_GAP_JUNCTION | 5.04e-05 | 90 | 206 | 8 | M4013 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | 5.33e-05 | 15 | 206 | 4 | MM14643 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 5.33e-05 | 15 | 206 | 4 | M47475 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 5.33e-05 | 15 | 206 | 4 | M47535 | |
| Pathway | WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS | 5.67e-05 | 29 | 206 | 5 | M39516 | |
| Pathway | REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ | 5.95e-05 | 6 | 206 | 3 | M27951 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY | 5.95e-05 | 6 | 206 | 3 | M47433 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX | 5.95e-05 | 6 | 206 | 3 | M47931 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1 | 5.95e-05 | 6 | 206 | 3 | M47932 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 7.02e-05 | 121 | 206 | 9 | M39823 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | 7.02e-05 | 16 | 206 | 4 | M639 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 9.08e-05 | 17 | 206 | 4 | M47376 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 9.27e-05 | 32 | 206 | 5 | MM1355 | |
| Pathway | KEGG_CHEMOKINE_SIGNALING_PATHWAY | 1.01e-04 | 188 | 206 | 11 | M4844 | |
| Pathway | REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS | 1.03e-04 | 7 | 206 | 3 | M29717 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 1.03e-04 | 7 | 206 | 3 | M19489 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 1.08e-04 | 33 | 206 | 5 | M9494 | |
| Pathway | WP_BDNFTRKB_SIGNALING | 1.08e-04 | 33 | 206 | 5 | M39532 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 1.10e-04 | 75 | 206 | 7 | M39568 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 1.15e-04 | 18 | 206 | 4 | M47580 | |
| Pathway | KEGG_VEGF_SIGNALING_PATHWAY | 1.20e-04 | 76 | 206 | 7 | M1749 | |
| Pathway | REACTOME_PI_METABOLISM | 1.30e-04 | 77 | 206 | 7 | MM14590 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 1.45e-04 | 19 | 206 | 4 | M27423 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 1.45e-04 | 19 | 206 | 4 | M47543 | |
| Pathway | WP_CHEMOKINE_SIGNALING | 1.56e-04 | 165 | 206 | 10 | M39400 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS | 1.63e-04 | 8 | 206 | 3 | M27919 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP | 1.63e-04 | 8 | 206 | 3 | M47935 | |
| Pathway | PID_GMCSF_PATHWAY | 1.66e-04 | 36 | 206 | 5 | M22 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 1.79e-04 | 20 | 206 | 4 | M39002 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | 1.79e-04 | 81 | 206 | 7 | M595 | |
| Pathway | WP_THERMOGENESIS | 1.83e-04 | 108 | 206 | 8 | M39746 | |
| Pathway | KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY | 1.83e-04 | 108 | 206 | 8 | M9904 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE | 2.15e-04 | 38 | 206 | 5 | M27536 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 2.18e-04 | 21 | 206 | 4 | M27485 | |
| Pathway | REACTOME_PI_METABOLISM | 2.25e-04 | 84 | 206 | 7 | M676 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.35e-04 | 112 | 206 | 8 | MM15214 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 2.42e-04 | 9 | 206 | 3 | M27156 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 2.42e-04 | 9 | 206 | 3 | M27173 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS | 2.42e-04 | 9 | 206 | 3 | M27904 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 2.44e-04 | 39 | 206 | 5 | MM1397 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 2.44e-04 | 39 | 206 | 5 | M1908 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 2.64e-04 | 22 | 206 | 4 | M26929 | |
| Pathway | WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING | 2.65e-04 | 144 | 206 | 9 | M39691 | |
| Pathway | WP_ENDOMETRIAL_CANCER | 3.08e-04 | 63 | 206 | 6 | M39623 | |
| Pathway | WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE | 3.15e-04 | 23 | 206 | 4 | M39843 | |
| Pathway | KEGG_PROSTATE_CANCER | 3.21e-04 | 89 | 206 | 7 | M13191 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 3.42e-04 | 10 | 206 | 3 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 3.42e-04 | 10 | 206 | 3 | MM14668 | |
| Pathway | PID_LYSOPHOSPHOLIPID_PATHWAY | 3.65e-04 | 65 | 206 | 6 | M15 | |
| Pathway | WP_CHEMOKINE_SIGNALING_PATHWAY | 3.76e-04 | 184 | 206 | 10 | MM15943 | |
| Pathway | WP_IL11_SIGNALING | 4.34e-04 | 44 | 206 | 5 | M39716 | |
| Pathway | PID_ERBB2_ERBB3_PATHWAY | 4.34e-04 | 44 | 206 | 5 | M175 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 4.40e-04 | 25 | 206 | 4 | M27865 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE | 4.65e-04 | 11 | 206 | 3 | M27535 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 4.65e-04 | 11 | 206 | 3 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 4.65e-04 | 11 | 206 | 3 | M47371 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 4.65e-04 | 11 | 206 | 3 | M27466 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 | 4.65e-04 | 11 | 206 | 3 | M27911 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 4.65e-04 | 11 | 206 | 3 | M27740 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 4.65e-04 | 11 | 206 | 3 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 4.65e-04 | 11 | 206 | 3 | M47432 | |
| Pathway | PID_MTOR_4PATHWAY | 5.05e-04 | 69 | 206 | 6 | M121 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_IN_CANCER | 5.14e-04 | 26 | 206 | 4 | M29535 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_ERK_SIGNALING_PATHWAY | 5.97e-04 | 27 | 206 | 4 | M47454 | |
| Pathway | KEGG_AXON_GUIDANCE | 6.11e-04 | 129 | 206 | 8 | M5539 | |
| Pathway | PID_PDGFRB_PATHWAY | 6.11e-04 | 129 | 206 | 8 | M186 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 6.14e-04 | 12 | 206 | 3 | M47369 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 6.14e-04 | 12 | 206 | 3 | M47815 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL | 6.14e-04 | 12 | 206 | 3 | MM14710 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 6.14e-04 | 12 | 206 | 3 | M29851 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 6.14e-04 | 12 | 206 | 3 | M39408 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY | 6.14e-04 | 12 | 206 | 3 | M47956 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 6.14e-04 | 12 | 206 | 3 | M12851 | |
| Pathway | PID_PI3KCI_PATHWAY | 6.52e-04 | 48 | 206 | 5 | M141 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 6.76e-04 | 131 | 206 | 8 | MM15717 | |
| Pathway | KEGG_MELANOGENESIS | 6.93e-04 | 101 | 206 | 7 | M7761 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 6.93e-04 | 101 | 206 | 7 | M1979 | |
| Pathway | PID_ARF6_TRAFFICKING_PATHWAY | 7.18e-04 | 49 | 206 | 5 | M67 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 7.34e-04 | 74 | 206 | 6 | M39857 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 7.48e-04 | 166 | 206 | 9 | M608 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 7.89e-04 | 13 | 206 | 3 | M47594 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 7.89e-04 | 13 | 206 | 3 | M1441 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 7.89e-04 | 13 | 206 | 3 | MM14553 | |
| Pathway | KEGG_THYROID_CANCER | 7.90e-04 | 29 | 206 | 4 | M523 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 7.90e-04 | 29 | 206 | 4 | MM1495 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 7.90e-04 | 29 | 206 | 4 | M779 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 8.46e-04 | 76 | 206 | 6 | M9052 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 9.01e-04 | 30 | 206 | 4 | M9664 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | 9.06e-04 | 77 | 206 | 6 | MM14513 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 9.23e-04 | 106 | 206 | 7 | M27077 | |
| Pathway | WP_PURINE_METABOLISM | 9.24e-04 | 171 | 206 | 9 | MM15909 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 9.94e-04 | 14 | 206 | 3 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 9.94e-04 | 14 | 206 | 3 | M47365 | |
| Pubmed | AARS1 MYCBP2 RPS6 EIF3E PSMC2 ME2 DHX15 URB1 DST SUPT6H HERC2 HECTD1 GCN1 PNP TUT7 SPAG9 HEATR1 KRR1 DIS3 MTOR SCAF11 ATIC CTNNA1 LTF LAS1L SNRNP200 PCM1 PCNT | 7.01e-13 | 653 | 278 | 28 | 22586326 | |
| Pubmed | TANC2 DLGAP1 MYCBP2 RGPD1 FYCO1 BCR DST NFATC3 HRAS DIAPH2 FBXO41 TLN2 STIP1 JAKMIP1 HERC2 TLK2 KRAS NRCAM KALRN WDR26 CCDC88C HOOK3 LZTS1 MTOR TJAP1 ERC2 CDK5RAP2 CTNNA1 CTNNB1 PCM1 PCNT | 6.00e-11 | 963 | 278 | 31 | 28671696 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TPM1 PDXDC1 UBA5 AARS1 RPS6 EIF3E PSMC2 POLA2 PGGT1B DHX15 EHBP1L1 PTPN12 TXNDC5 CIAPIN1 STIP1 HECTD1 GCN1 TARS1 SFN PNP OGFR ERO1A HAT1 CC2D1B SPAG9 VPS26A KLC4 RUFY1 WDR26 DIS3 EEF1B2 MTOR RPUSD2 ATIC CTNNA1 COASY IKBKB SNRNP200 | 1.57e-10 | 1455 | 278 | 38 | 22863883 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ACACB KIAA0232 BACH2 RGPD1 PSMC2 BCR RBSN MAST4 NFATC3 CIAPIN1 EXOSC6 HERC2 FHIP2B HUS1 CIP2A TUT7 CNTRL KLC4 RUFY1 TFCP2 PDHX GRIP1 CCDC88C HOOK3 ITSN2 LYN PCM1 PCNT | 3.48e-10 | 853 | 278 | 28 | 28718761 |
| Pubmed | AARS1 GALK1 MYCBP2 PDGFRB RPS6 EIF3E PSMC2 FYCO1 BCR ITPR2 PIK3R4 EHBP1L1 KIDINS220 GLG1 MLH1 HERC2 GCN1 KRAS NRAS ERO1A CNTRL DOCK10 HEATR1 KRR1 DIS3 MTOR CHTF18 LSS ATIC LAS1L ARHGAP45 PCM1 PCNT | 3.99e-10 | 1168 | 278 | 33 | 19946888 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | PDXDC1 AARS1 GALK1 MYCBP2 RPS6 EIF3E FYCO1 ALDH1L1 PHGDH DHX15 DST TXNDC5 GLG1 STIP1 GCN1 TARS1 SFN PNP KRAS NRAS CNTRL EEF1B2 PTPA ATIC CTNNA1 SNRNP200 HYDIN | 4.84e-10 | 807 | 278 | 27 | 30575818 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | AARS1 GALK1 CASP14 MYCBP2 RPS6 EIF3E PSMC2 PHGDH PIK3R4 DHX15 URB1 PTPN12 DST MLH1 HERC2 GCN1 TARS1 PNP TUT7 DOCK10 HEATR1 VPS26A KRR1 DIS3 RLF EEF1B2 ARHGEF40 RDH11 CHTF18 SHCBP1 KDM2A ATIC LTF LAS1L SNRNP200 | 1.15e-09 | 1353 | 278 | 35 | 29467282 |
| Pubmed | AARS1 GALK1 ATR MYCBP2 FYCO1 ITPR2 URB1 TXNDC5 HECTD1 GCN1 ERO1A CNTRL RUFY1 DIS3 PCM1 PCNT | 1.56e-09 | 285 | 278 | 16 | 32838362 | |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 1.73e-09 | 8 | 278 | 5 | 12634303 | |
| Pubmed | MYCBP2 KIAA0232 SMC5 URB1 DST TLN2 GCN1 DOCK10 SPAG9 DIS3 ERC2 KDM2A SNRNP200 PCNT | 4.51e-09 | 225 | 278 | 14 | 12168954 | |
| Pubmed | TPM1 GALK1 EIF3E MRPS27 PSMC2 PHGDH ITPR2 DHX15 URB1 BNIP1 DST COG1 STIP1 IFI44L GCN1 KRAS ERO1A CIP2A HAT1 HEATR1 KRR1 WDR26 DIS3 EEF1B2 HOOK3 RDH11 LMX1B MTOR CTNNA1 LTF CTNNB1 LAS1L IKBKB SNRNP200 PCM1 | 5.66e-09 | 1440 | 278 | 35 | 30833792 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | PDXDC1 AARS1 GALK1 LEMD3 MRPS27 PSMC2 BCR PTPN12 KIDINS220 TXNDC5 STIP1 HECTD1 GCN1 SFN ERO1A CIP2A SPAG9 HEATR1 VPS26A IDI1 WDR26 DIS3 EEF1B2 MTOR SHCBP1 CTNNA1 SNRNP200 PCM1 | 6.42e-09 | 974 | 278 | 28 | 28675297 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 MYCBP2 SPEG OBSCN FYCO1 ITGA5 BCR ADCY7 ITPR2 URB1 EHBP1L1 DST NFATC1 EXOSC6 DIAPH2 TLN2 HERC2 HECTD1 GCN1 PICK1 KALRN KMT5C SBNO2 PIKFYVE CCDC88C ARHGEF40 LMX1B MTOR PCNT MYBL2 | 6.57e-09 | 1105 | 278 | 30 | 35748872 |
| Pubmed | TANC2 ACACB RGPD1 MRPS27 ITGA5 ADCY2 EHBP1L1 TXNDC5 PI4KB FER1L5 RAB4A FHIP2B HUS1 IDI1 SEC31B LMOD2 LZTS1 UNC5C ITSN2 CDK5RAP2 ARHGAP45 MYBL2 | 1.23e-08 | 638 | 278 | 22 | 31182584 | |
| Pubmed | PDXDC1 UBA5 EIF3E PSMC2 PHGDH DHX15 TXNDC5 SUPT6H STIP1 HECTD1 GCN1 TARS1 CIP2A HAT1 SPAG9 HEATR1 WDR26 DIS3 MTOR CTNNB1 LAS1L SNRNP200 | 1.23e-08 | 638 | 278 | 22 | 33239621 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | AARS1 ATR PDGFRB RPS6 EIF3E MRPS27 ME2 PHGDH PIK3R4 DHX15 URB1 KIDINS220 TXNDC5 SUPT6H EXOSC6 TLN2 STIP1 MYO18B GCN1 TARS1 ERO1A CHAF1A HAT1 HEATR1 KRR1 DIS3 TFCP2 EEF1B2 RDH11 MTOR ATIC LTF COASY SNRNP200 | 1.50e-08 | 1425 | 278 | 34 | 30948266 |
| Pubmed | DLGAP1 AARS1 MYCBP2 PDGFRB SPTB MCF2L2 BRWD3 PIK3R4 DST COG1 MKLN1 ASTN2 TLN2 JAKMIP1 HERC2 HECTD1 TARS1 PICK1 NRCAM KALRN CHD9 VPS26A SEC31B WDR26 FBH1 ERC2 ANKRD24 ATIC CTNNA1 SNRNP200 PCM1 PCNT | 1.54e-08 | 1285 | 278 | 32 | 35914814 | |
| Pubmed | TPM1 NUDT18 TANC2 DLGAP1 INPP4A RPS6 SPTB ALDH1L1 ITGA2 BCR PHGDH ITPR2 PIK3R4 DHX15 KIDINS220 DST FBXO41 TLN2 STIP1 TARS1 VPS18 KRT78 NRCAM KALRN RAB3D PDHX EEF1B2 LZTS1 ITSN2 ERC2 CTNNA1 CTNNB1 SNRNP200 PCM1 | 1.66e-08 | 1431 | 278 | 34 | 37142655 | |
| Pubmed | 1.99e-08 | 5 | 278 | 4 | 16356174 | ||
| Pubmed | NFAT: ubiquitous regulator of cell differentiation and adaptation. | 1.99e-08 | 5 | 278 | 4 | 11877454 | |
| Pubmed | TPM1 FAM184B ACACB ARMC3 RPS6 RAB22A RGPD1 ANKRD30B STOX1 EPX PRPS1L1 BNIP1 DST COG1 JAKMIP1 CCDC89 PICK1 SFN CHAF1A CNTRL RAB3D CC2D1B HEATR1 SKI RNF17 EEF1B2 RDH11 UNC5C ITSN2 ANKRD30A ERC2 CFAP46 PCNT MYBPC2 | 2.00e-08 | 1442 | 278 | 34 | 35575683 | |
| Pubmed | TPM1 MYCBP2 RPS6 SPTB OBSCN PHGDH DHX15 DST SUPT6H MKLN1 MED12L STIP1 MYO18B KALRN TRIM54 HOOK3 CDK5RAP2 KDM2A MYBPC2 | 2.50e-08 | 497 | 278 | 19 | 23414517 | |
| Pubmed | A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. | 5.92e-08 | 6 | 278 | 4 | 16141075 | |
| Pubmed | 5.92e-08 | 6 | 278 | 4 | 25728138 | ||
| Pubmed | TPM1 FAM184B OBSCN CEACAM4 ME2 PGGT1B URB1 EML5 GLG1 MKLN1 AFF1 FHIP2B TLK2 DPAGT1 ERO1A TUT7 CNTRL RAB3D HEATR1 KRR1 DIS3 SBNO2 KLHL5 UNC5C CDK5RAP2 NFAT5 ATP6V0A2 PCNT | 6.13e-08 | 1084 | 278 | 28 | 11544199 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | UBA5 AARS1 CASP14 RPS6 EIF3E ME2 PHGDH DHX15 PTPN12 TXNDC5 GLG1 CIAPIN1 STIP1 GCN1 SFN DPAGT1 KRT78 NRAS OGFR ERO1A HAT1 VPS26A DIS3 EEF1B2 HOOK3 RDH11 MTOR CHTF18 ATIC CTNNA1 CTNNB1 ILKAP | 6.38e-08 | 1367 | 278 | 32 | 32687490 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CASP14 MYCBP2 RPS6 PHGDH ITPR2 DHX15 URB1 DST TXNDC5 SUPT6H EXOSC6 STIP1 HERC2 GCN1 TARS1 KRT78 HEATR1 EEF1B2 HOOK3 ATIC CTNNA1 CTNNB1 LAS1L LYN SNRNP200 PCM1 PCNT | 7.08e-08 | 1024 | 278 | 27 | 24711643 |
| Pubmed | TPM1 IMPA1 RPS6 EIF3E PSMC2 PHGDH DHX15 TXNDC5 HRAS MLH1 AFF1 STIP1 HECTD1 GCN1 TARS1 SFN KRAS ANKRD35 VPS18 PPFIBP2 CHD9 DIS3 PPM1B EEF1B2 CHTF18 ATIC CTNNA1 CTNNB1 LYN NFAT5 | 9.46e-08 | 1247 | 278 | 30 | 27684187 | |
| Pubmed | AARS1 RPS6 EIF3E PSMC2 PHGDH DHX15 TXNDC5 ODR4 EXOSC6 JAKMIP1 KRR1 SKI WDR26 DIS3 PDHX PPM1B CCDC88C SCAF11 SNRNP200 | 1.25e-07 | 551 | 278 | 19 | 34728620 | |
| Pubmed | FAM184B MYCBP2 LEMD3 MRPS27 ME2 DMXL1 ITPR2 PM20D2 URB1 BNIP1 KIDINS220 TXNDC5 SUPT6H GLG1 STIP1 HERC2 TARS1 PNP ERO1A CIP2A HEATR1 TFCP2 PDHX CDK5RAP2 LSS CTNNA1 COASY CTNNB1 LAS1L SNRNP200 PCM1 ATP6V0A2 PCNT | 1.34e-07 | 1487 | 278 | 33 | 33957083 | |
| Pubmed | 1.37e-07 | 7 | 278 | 4 | 21295565 | ||
| Pubmed | 1.37e-07 | 7 | 278 | 4 | 22199277 | ||
| Pubmed | 1.37e-07 | 7 | 278 | 4 | 38109525 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TPM1 TANC2 CCP110 AARS1 MYCBP2 KIAA0232 BCR PIK3R4 RBSN DST MAST4 NFATC3 PI4KB HECTD1 SFN KRT78 ARHGEF5 KLC4 WDR26 GRIP1 CCDC88C MTOR MUSK PCM1 | 1.44e-07 | 861 | 278 | 24 | 36931259 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | DLGAP1 MYCBP2 KIAA0232 SSC4D ASB8 PI4KB EID1 MLH1 JAKMIP1 PICK1 ANKRD35 VPS18 CNTRL KLC4 TFCP2 GRIP1 TJAP1 ANKRD24 CTNNB1 | 1.60e-07 | 560 | 278 | 19 | 21653829 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PDXDC1 AARS1 LEMD3 PSMC2 PHGDH URB1 BNIP1 KIDINS220 COG1 HECTD1 GCN1 TARS1 CIP2A TUT7 HAT1 HEATR1 CCDC167 URGCP ARHGEF40 RDH11 MTOR LSS ATIC CTNNA1 CTNNB1 | 1.96e-07 | 942 | 278 | 25 | 31073040 |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | TPM1 PSMC2 FYCO1 PHGDH DHX15 STIP1 HECTD1 HAT1 SPAG9 EEF1B2 SNRNP200 | 2.50e-07 | 180 | 278 | 11 | 30110629 |
| Pubmed | 2.73e-07 | 8 | 278 | 4 | 12370307 | ||
| Pubmed | UBA5 AARS1 DDX59 INPP4A CCDC178 SMC5 POLA2 PGGT1B RBSN ODR4 ELMOD3 STIP1 HECTD1 GCN1 TLK2 RAD51D VPS18 CHAF1A HEATR1 RUFY1 RLF GLCE LSS KDM2A ATIC LAS1L PCM1 PADI3 ATP6V0A2 PCNT | 3.54e-07 | 1327 | 278 | 30 | 32694731 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | PDXDC1 GALK1 MYCBP2 RPS6 EIF3E RGPD1 PSMC2 PHGDH PIK3R4 DHX15 URB1 HRAS HECTD1 GCN1 TARS1 SFN PNP KRAS DDX12P NRAS HAT1 WDR26 DIS3 EEF1B2 CHTF18 CTNNB1 LAS1L SNRNP200 PRAME | 3.72e-07 | 1257 | 278 | 29 | 37317656 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYCBP2 INPP4A KIAA0232 SPTB OBSCN BCR ME2 BRWD3 KIDINS220 NFATC1 SUPT6H MKLN1 AFF1 ASTN2 HECTD1 TET3 SCGB2B2 TRMT9B PPFIBP2 CHD9 SKI SBNO2 RLF RDH11 TJAP1 LSS KDM2A SCAF11 ANKRD24 NFAT5 PCM1 PCNT | 4.28e-07 | 1489 | 278 | 32 | 28611215 |
| Pubmed | Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules. | 5.05e-07 | 3 | 278 | 3 | 28116986 | |
| Pubmed | Mutations of RAS gene family in specimens of bladder cancer. | 5.05e-07 | 3 | 278 | 3 | 19101897 | |
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 33620658 | ||
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 22589270 | ||
| Pubmed | A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. | 5.05e-07 | 3 | 278 | 3 | 23496764 | |
| Pubmed | Distribution of p21ras during primary palate formation of non-cleft and cleft strains of mice. | 5.05e-07 | 3 | 278 | 3 | 7776260 | |
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 25801914 | ||
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 25788415 | ||
| Pubmed | Comparison of liver oncogenic potential among human RAS isoforms. | 5.05e-07 | 3 | 278 | 3 | 26799184 | |
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 31906952 | ||
| Pubmed | Partial functional overlap of the three ras genes in mouse embryonic development. | 5.05e-07 | 3 | 278 | 3 | 18059342 | |
| Pubmed | Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series. | 5.05e-07 | 3 | 278 | 3 | 23240926 | |
| Pubmed | Absolute Quantification of Endogenous Ras Isoform Abundance. | 5.05e-07 | 3 | 278 | 3 | 26560143 | |
| Pubmed | Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. | 5.05e-07 | 3 | 278 | 3 | 17712732 | |
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 24222113 | ||
| Pubmed | Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. | 5.05e-07 | 3 | 278 | 3 | 22945650 | |
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 19303097 | ||
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 27911734 | ||
| Pubmed | Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. | 5.05e-07 | 3 | 278 | 3 | 20150643 | |
| Pubmed | K-ras is an essential gene in the mouse with partial functional overlap with N-ras. | 5.05e-07 | 3 | 278 | 3 | 9334313 | |
| Pubmed | RAS gene mutations and histomorphometric measurements in oral squamous cell carcinoma. | 5.05e-07 | 3 | 278 | 3 | 37013448 | |
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 25977330 | ||
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 28630043 | ||
| Pubmed | Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. | 5.05e-07 | 3 | 278 | 3 | 28259994 | |
| Pubmed | The variable phenotype and low-risk nature of RAS-positive thyroid nodules. | 5.05e-07 | 3 | 278 | 3 | 26253102 | |
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 16573741 | ||
| Pubmed | Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. | 5.05e-07 | 3 | 278 | 3 | 20090846 | |
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 21737741 | ||
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 17943694 | ||
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 28202657 | ||
| Pubmed | Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma. | 5.05e-07 | 3 | 278 | 3 | 16761621 | |
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 20971740 | ||
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 27119512 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PDXDC1 MYCBP2 EIF3E PSMC2 PIK3R4 PI4KB MKLN1 STIP1 HERC2 GCN1 TARS1 TLK2 RAD51D VPS18 KRT78 HUS1 CHAF1A SPAG9 HEATR1 KLC4 PPM1B EEF1B2 SHCBP1 ATIC LTF CTNNB1 LAS1L LYN SNRNP200 | 5.73e-07 | 1284 | 278 | 29 | 17353931 |
| Pubmed | TANC2 DLGAP1 IMPA1 ACACB MYCBP2 RPS6 RGPD1 MRPS27 PSMC2 BCR PHGDH RBSN TXNDC5 GLG1 MKLN1 FBXO41 TLN2 STIP1 GCN1 NRCAM KALRN OGFR WDR26 PDHX EEF1B2 CTNNB1 PCM1 | 5.74e-07 | 1139 | 278 | 27 | 36417873 | |
| Pubmed | TANC2 CCP110 MRPS27 ASTN2 HECTD1 TANGO6 PDZRN4 VPS18 CIP2A CC2D1B SPAG9 PIKFYVE CCDC88C GLCE KDM2A ANKRD24 SNRNP200 | 5.83e-07 | 493 | 278 | 17 | 15368895 | |
| Pubmed | TPM1 PDXDC1 AARS1 DDX59 MYCBP2 PSMC2 ITGA5 POLA2 PHGDH PM20D2 DHX15 PTPN12 KIDINS220 DST TXNDC5 GLG1 MLH1 STIP1 HECTD1 PNP ERO1A EEF1B2 PTPA ARHGEF40 KDM2A CTNNB1 IKBKB LYN PCM1 | 7.02e-07 | 1297 | 278 | 29 | 33545068 | |
| Pubmed | PDXDC1 UBA5 AARS1 EIF3E PSMC2 PHGDH TXNDC5 COG1 AP5Z1 CIAPIN1 GCN1 TARS1 PNP TANGO6 OGFR SPAG9 IDI1 DIS3 PDHX EEF1B2 PTPA ATIC CTNNA1 | 7.70e-07 | 878 | 278 | 23 | 37223481 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | ATR RNF112 HERC2 HECTD1 GCN1 KRT78 TUT7 ARHGEF40 MTOR ANKRD30A SNRNP200 | 7.88e-07 | 202 | 278 | 11 | 33005030 |
| Pubmed | Spatial and temporal regulation of coronary vessel formation by calcineurin-NFAT signaling. | 8.08e-07 | 10 | 278 | 4 | 19710169 | |
| Pubmed | EIF3E PSMC2 BCR PHGDH DHX15 COG1 ODR4 SUPT6H TANGO6 KRAS CNTRL ABCB6 HEATR1 VPS26A RNF17 CCDC39 GSTM2 RDH11 LTF SNRNP200 ILKAP | 9.01e-07 | 754 | 278 | 21 | 35906200 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | TPM1 CCP110 MYCBP2 EIF3E MRPS27 FYCO1 POLA2 URB1 JAKMIP1 HERC2 HECTD1 GCN1 ERO1A TUT7 CNTRL HEATR1 WDR26 MTOR CDK5RAP2 PCM1 PCNT | 9.01e-07 | 754 | 278 | 21 | 33060197 |
| Pubmed | TANC2 DLGAP1 MYCBP2 ADCY5 DST FBXO41 RAB12 NRCAM CPEB3 GRM7 ERC2 CTNNA1 CTNNB1 PCM1 | 9.47e-07 | 347 | 278 | 14 | 17114649 | |
| Pubmed | MCF2L2 DST HECTD1 TANGO6 NRCAM ITSN2 CDK5RAP2 NFAT5 SNRNP200 | 1.11e-06 | 130 | 278 | 9 | 12421765 | |
| Pubmed | SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras. | 1.26e-06 | 11 | 278 | 4 | 28263956 | |
| Pubmed | PDXDC1 ACACB LEMD3 RPS6 DMXL1 RBSN KIDINS220 DST PI4KB GCN1 TARS1 CNTRL SPAG9 RUFY1 AK8 UNC5C TJAP1 CDK5RAP2 SNRNP200 PCM1 ATP6V0A2 | 1.45e-06 | 777 | 278 | 21 | 35844135 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CCP110 BACH2 BCR NFATC1 APEX2 NFATC3 SUPT6H STIP1 DSCC1 CIP2A RUFY1 DIS3 PIKFYVE ERC2 CTNNB1 PCM1 PCNT MYBL2 | 1.49e-06 | 588 | 278 | 18 | 38580884 |
| Pubmed | The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer. | 1.66e-06 | 71 | 278 | 7 | 29346117 | |
| Pubmed | ACACB MYCBP2 INPP4A RGPD1 BCR DST GCN1 TANGO6 CIP2A RUFY1 WDR26 RLF PCM1 PCNT MYBL2 | 1.66e-06 | 418 | 278 | 15 | 34709266 | |
| Pubmed | 2.01e-06 | 4 | 278 | 3 | 20152126 | ||
| Pubmed | Transcription factors of the NFAT family: regulation and function. | 2.01e-06 | 4 | 278 | 3 | 9143705 | |
| Pubmed | 2.01e-06 | 4 | 278 | 3 | 10085069 | ||
| Pubmed | 2.01e-06 | 4 | 278 | 3 | 38849523 | ||
| Pubmed | 2.01e-06 | 4 | 278 | 3 | 9674433 | ||
| Pubmed | Quantification of spatiotemporal patterns of Ras isoform expression during development. | 2.01e-06 | 4 | 278 | 3 | 28117393 | |
| Pubmed | 2.01e-06 | 4 | 278 | 3 | 25918731 | ||
| Pubmed | The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions. | 2.01e-06 | 4 | 278 | 3 | 27936046 | |
| Pubmed | Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury. | 2.01e-06 | 4 | 278 | 3 | 29502968 | |
| Pubmed | NFAT isoforms play distinct roles in TNFα-induced retinal leukostasis. | 2.01e-06 | 4 | 278 | 3 | 26527057 | |
| Interaction | YWHAQ interactions | TPM1 TANC2 CCP110 DLGAP1 MYCBP2 SPEG SPTB MRPS27 SMC5 BCR DST MAST4 TXNDC5 NFATC1 NFATC3 NFATC4 PI4KB ANKRD18A STIP1 ZCCHC7 FGR HECTD1 GCN1 SFN KRAS HUS1 PPFIBP2 ARHGEF5 CHAF1A HAT1 SPAG9 KRR1 KLC4 RUFY1 TFCP2 GRIP1 CCDC88C HOOK3 MTOR SHCBP1 CTNNB1 PCM1 | 1.65e-09 | 1118 | 272 | 42 | int:YWHAQ |
| Interaction | TNIK interactions | TANC2 DLGAP1 MYCBP2 BCR DST PI4KB HRAS HERC2 SFN TLK2 KRAS NRAS KALRN ERO1A LZTS1 ERC2 CTNNA1 CTNNB1 IKBKB LYN PCM1 | 5.81e-08 | 381 | 272 | 21 | int:TNIK |
| Interaction | SIRT7 interactions | AARS1 ATR MYCBP2 RPS6 EIF3E PSMC2 ME2 DHX15 URB1 DST SUPT6H HERC2 HECTD1 GCN1 PNP TUT7 SPAG9 HEATR1 KRR1 DIS3 MTOR SCAF11 ATIC CTNNA1 LTF LAS1L SNRNP200 PCM1 PCNT | 3.27e-07 | 744 | 272 | 29 | int:SIRT7 |
| Interaction | YWHAZ interactions | TANC2 CCP110 DLGAP1 MYCBP2 KIAA0232 SPEG SMC5 BCR DST MAST4 NFATC3 NFATC4 PI4KB STIP1 JAKMIP1 ZCCHC7 HERC2 HECTD1 SFN TLK2 KRAS KRT78 PPFIBP2 ARHGEF5 ERO1A CHAF1A KRR1 KLC4 RUFY1 GRIP1 CCDC88C EEF1B2 MTOR SHCBP1 CTNNA3 CDK5RAP2 SCAF11 CTNNB1 PCM1 PCNT | 1.27e-06 | 1319 | 272 | 40 | int:YWHAZ |
| Interaction | YWHAH interactions | TANC2 CCP110 DLGAP1 MYCBP2 KIAA0232 SPEG PSMC2 POLA2 BCR PIK3R4 RBSN DST MAST4 NFATC3 PI4KB JAKMIP1 HECTD1 TARS1 SFN KRAS KRT78 EVC2 PPFIBP2 ARHGEF5 CNTRL KRR1 KLC4 WDR26 CCDC39 GRIP1 CCDC88C MTOR SHCBP1 PCM1 PCNT | 2.28e-06 | 1102 | 272 | 35 | int:YWHAH |
| Interaction | SFN interactions | TANC2 CCP110 AARS1 CASP14 MYCBP2 KIAA0232 RPS6 BCR DHX15 DST MAST4 NFATC3 PI4KB ZCCHC7 HECTD1 SFN KRAS PPFIBP2 ARHGEF5 KLC4 WDR26 GRIP1 CCDC88C MTOR SHCBP1 CTNNB1 | 2.70e-06 | 692 | 272 | 26 | int:SFN |
| Interaction | TULP3 interactions | BACH2 SPTB BCR PM20D2 DST TXNDC5 GLG1 HRAS MYO18B TLK2 KRAS NRAS HAT1 CHD9 DIS3 LYN MYBPC2 | 5.18e-06 | 346 | 272 | 17 | int:TULP3 |
| Interaction | LAMTOR1 interactions | PDXDC1 CCP110 PSMC2 FYCO1 ITGA2 DMXL1 PIK3R4 KIDINS220 DST PI4KB HRAS DIAPH2 STIP1 RAB4A KRAS VPS18 NRAS SPAG9 KLC4 RUFY1 TFCP2 PIKFYVE TJAP1 IKBKB LYN ATP6V0A2 | 5.79e-06 | 722 | 272 | 26 | int:LAMTOR1 |
| Interaction | MCAM interactions | PDXDC1 LEMD3 INPP4B EHBP1L1 AFAP1L2 KIDINS220 DST HRAS ELMOD3 RAB4A KRAS NRAS DOCK10 ABCB6 LZTS1 MTOR CTNNA1 CTNNB1 LYN ATP6V0A2 | 6.26e-06 | 468 | 272 | 20 | int:MCAM |
| Interaction | PLCH1 interactions | 6.93e-06 | 74 | 272 | 8 | int:PLCH1 | |
| Interaction | MACF1 interactions | MYCBP2 BRWD3 RBSN HERC2 HECTD1 SFN TANGO6 KRAS NRAS NRCAM KALRN CTNNA1 LYN PCNT | 7.19e-06 | 247 | 272 | 14 | int:MACF1 |
| Interaction | YWHAB interactions | TANC2 CCP110 DLGAP1 MYCBP2 KIAA0232 SPEG BCR PIK3R4 DHX15 DST MAST4 NFATC3 PI4KB JAKMIP1 ZCCHC7 HECTD1 SFN KRAS ARHGEF5 CHAF1A HAT1 KRR1 KLC4 TFCP2 GRIP1 CCDC88C HOOK3 MTOR SHCBP1 IKBKB SNRNP200 PCM1 | 7.34e-06 | 1014 | 272 | 32 | int:YWHAB |
| Interaction | GOLGA1 interactions | PDXDC1 UBA5 CCP110 RGPD1 DMXL1 DST COG1 RUFY1 LZTS1 TJAP1 PCM1 PCNT | 7.56e-06 | 183 | 272 | 12 | int:GOLGA1 |
| Interaction | ANKRD20A1 interactions | 9.94e-06 | 11 | 272 | 4 | int:ANKRD20A1 | |
| Interaction | TANC1 interactions | 1.37e-05 | 106 | 272 | 9 | int:TANC1 | |
| Interaction | TPTE2 interactions | 1.78e-05 | 84 | 272 | 8 | int:TPTE2 | |
| Interaction | SPTBN1 interactions | TPM1 DLGAP1 MYCBP2 HRAS STIP1 HERC2 SFN KRAS NRAS KALRN TFCP2 PPM1B GOLGA6L10 CTNNA1 LYN CFAP46 PCNT MYBL2 | 1.82e-05 | 421 | 272 | 18 | int:SPTBN1 |
| Interaction | NDRG1 interactions | RPS6 EIF3E PSMC2 DHX15 HRAS MLH1 RAB4A TARS1 KRAS NRAS SPAG9 CTNNB1 LYN | 1.98e-05 | 235 | 272 | 13 | int:NDRG1 |
| Interaction | NR3C1 interactions | TANC2 ACACB RGPD1 MRPS27 ITGA5 ADCY2 PHGDH EHBP1L1 TXNDC5 NFATC1 PI4KB FER1L5 RAB4A FHIP2B SFN HUS1 CHD9 IDI1 SEC31B LMOD2 PDHX GRIP1 LZTS1 UNC5C ITSN2 CDK5RAP2 LSS CTNNB1 ARHGAP45 MYBL2 | 2.29e-05 | 974 | 272 | 30 | int:NR3C1 |
| Interaction | SLITRK2 interactions | 2.38e-05 | 5 | 272 | 3 | int:SLITRK2 | |
| Interaction | AGR2 interactions | PDXDC1 AARS1 GALK1 MYCBP2 RPS6 EIF3E FYCO1 ALDH1L1 PHGDH DHX15 DST TXNDC5 GLG1 MLH1 STIP1 GCN1 TARS1 SFN PNP KRAS NRAS ERO1A CNTRL EEF1B2 PTPA ATIC CTNNA1 SNRNP200 HYDIN | 2.73e-05 | 934 | 272 | 29 | int:AGR2 |
| Interaction | FRAT2 interactions | 2.73e-05 | 27 | 272 | 5 | int:FRAT2 | |
| Interaction | DIAPH1 interactions | DLGAP1 MRPS27 DIAPH2 TLN2 STIP1 KRAS TUT7 KLC4 SKI RUFY1 MTOR | 2.84e-05 | 176 | 272 | 11 | int:DIAPH1 |
| Interaction | PPFIA1 interactions | POLA2 HRAS HERC2 PICK1 SFN KRAS NRAS PPFIBP2 HAT1 HOOK3 ERC2 LYN | 3.61e-05 | 214 | 272 | 12 | int:PPFIA1 |
| Interaction | DST interactions | PDXDC1 UBA5 MYCBP2 PDGFRB DST HERC2 RAB4A SFN KRAS ITSN2 CTNNB1 LYN PCNT MYBPC2 | 3.84e-05 | 287 | 272 | 14 | int:DST |
| Interaction | ANKRD20A4P interactions | 4.72e-05 | 6 | 272 | 3 | int:ANKRD20A4P | |
| Interaction | HEPH interactions | 4.72e-05 | 6 | 272 | 3 | int:HEPH | |
| Interaction | CCDC88C interactions | 4.81e-05 | 71 | 272 | 7 | int:CCDC88C | |
| Interaction | SPTAN1 interactions | DLGAP1 MYCBP2 SPTB EHBP1L1 DST HRAS MLH1 STIP1 RAB4A SFN KRAS NRAS KALRN TFCP2 PPM1B CTNNA1 CTNNB1 LYN PCNT | 4.81e-05 | 496 | 272 | 19 | int:SPTAN1 |
| Interaction | ELMOD3 interactions | 5.20e-05 | 16 | 272 | 4 | int:ELMOD3 | |
| Interaction | SAMSN1 interactions | 5.20e-05 | 16 | 272 | 4 | int:SAMSN1 | |
| Interaction | ANK2 interactions | 5.48e-05 | 98 | 272 | 8 | int:ANK2 | |
| Interaction | EED interactions | TPM1 PDXDC1 AARS1 GALK1 IMPA1 ACACB MYCBP2 RPS6 EIF3E OBSCN PSMC2 SMC5 PHGDH DMXL1 DHX15 URB1 TXNDC5 SUPT6H HERC2 HECTD1 TARS1 DNMT3A VPS18 CIP2A HEATR1 KRR1 DIS3 EEF1B2 ITSN2 KDM2A ATIC CTNNA1 CTNNB1 LAS1L SNRNP200 PCM1 PCNT MYBL2 | 5.92e-05 | 1445 | 272 | 38 | int:EED |
| Interaction | RFC4 interactions | RPS6 SMC5 POLA2 NFATC1 MLH1 DSCC1 HECTD1 KRAS HUS1 SPAG9 CHTF18 PRAME | 6.39e-05 | 227 | 272 | 12 | int:RFC4 |
| Interaction | GSK3A interactions | CCP110 ACACB RGPD1 BCR DHX15 PTPN12 KIDINS220 DST MAST4 HECTD1 SFN CIP2A CHTF18 ATIC CTNNA1 LTF CTNNB1 PCM1 | 6.48e-05 | 464 | 272 | 18 | int:GSK3A |
| Interaction | FAM81B interactions | 6.73e-05 | 17 | 272 | 4 | int:FAM81B | |
| Interaction | DNAJC7 interactions | TPM1 DMXL1 EML5 NFATC1 STIP1 HERC2 TARS1 SFN TANGO6 EVC2 HUS1 RUFY1 URGCP CDK5RAP2 LSS LAS1L PCNT | 7.13e-05 | 425 | 272 | 17 | int:DNAJC7 |
| Interaction | CHMP6 interactions | 7.52e-05 | 33 | 272 | 5 | int:CHMP6 | |
| Interaction | YWHAG interactions | TPM1 TANC2 CCP110 DLGAP1 AARS1 MYCBP2 KIAA0232 SPEG BCR PIK3R4 DHX15 DST MAST4 TXNDC5 NFATC3 PI4KB STIP1 JAKMIP1 HECTD1 SFN KRAS PPFIBP2 ARHGEF5 CHAF1A KRR1 KLC4 GRIP1 CCDC88C MTOR SHCBP1 SCAF11 ATIC SNRNP200 PCM1 | 7.62e-05 | 1248 | 272 | 34 | int:YWHAG |
| Interaction | SEMA4C interactions | 7.65e-05 | 163 | 272 | 10 | int:SEMA4C | |
| Interaction | ANKRD20A2P interactions | 8.18e-05 | 7 | 272 | 3 | int:ANKRD20A2P | |
| Interaction | KIF20A interactions | RPS6 SPTB MCF2L2 PHGDH ITPR2 DHX15 URB1 KIDINS220 COG1 SUPT6H HRAS AFF1 ANKRD18A HERC2 GCN1 TET3 RAB12 ANKRD35 TRIM54 SPAG9 HEATR1 KRR1 SEC31B LZTS1 CDK5RAP2 CTNNB1 LYN SNRNP200 PCM1 FAM83A | 9.33e-05 | 1052 | 272 | 30 | int:KIF20A |
| Interaction | MSH2 interactions | AARS1 CASP14 ATR ALDH1L1 INPP4B DHX15 CIAPIN1 HRAS MLH1 STIP1 HECTD1 HUS1 CHAF1A SNRNP200 | 9.74e-05 | 313 | 272 | 14 | int:MSH2 |
| Interaction | DNAI2 interactions | 1.04e-04 | 80 | 272 | 7 | int:DNAI2 | |
| Interaction | SHISA2 interactions | 1.07e-04 | 19 | 272 | 4 | int:SHISA2 | |
| Interaction | LRRC31 interactions | ATR RNF112 HERC2 HECTD1 GCN1 KRT78 TUT7 ARHGEF40 MTOR ANKRD30A SNRNP200 | 1.13e-04 | 205 | 272 | 11 | int:LRRC31 |
| Interaction | GSK3B interactions | CCP110 AARS1 CASP14 ACACB RGPD1 MRPS27 PSMC2 BCR PHGDH PTPN12 KIDINS220 DST MAST4 NFATC1 HERC2 HECTD1 PICK1 CIP2A PTPA MTOR ATIC CTNNA1 LTF CTNNB1 PCM1 ILKAP | 1.29e-04 | 868 | 272 | 26 | int:GSK3B |
| Interaction | EPHA3 interactions | 1.32e-04 | 111 | 272 | 8 | int:EPHA3 | |
| Interaction | ZGPAT interactions | ZNF177 DHX15 LDHD CARD9 KRAS TRIM54 HAT1 LZTS1 CTNNA1 SNRNP200 | 1.45e-04 | 176 | 272 | 10 | int:ZGPAT |
| Interaction | ARHGEF5 interactions | 1.52e-04 | 85 | 272 | 7 | int:ARHGEF5 | |
| Interaction | CBX8 interactions | RPS6 BACH2 IKZF1 SMC5 CARD9 JAKMIP1 HECTD1 PICK1 TRIM54 SPAG9 KRR1 TFCP2 | 1.53e-04 | 249 | 272 | 12 | int:CBX8 |
| Interaction | PCNA interactions | OBSCN POLA2 DHX15 APEX2 ASB8 MLH1 DSCC1 HECTD1 TLK2 KRAS HUS1 CHAF1A SKI HOOK3 FBH1 MTOR CHTF18 CTNNB1 | 1.54e-04 | 497 | 272 | 18 | int:PCNA |
| Interaction | BRCA1 interactions | TPM1 AARS1 ATR RPS6 EIF3E OBSCN PSMC2 POLR2M SMC5 PHGDH DHX15 DST SUPT6H MLH1 STIP1 HERC2 GCN1 TARS1 HUS1 OGFR CIP2A CHAF1A CHD9 SPAG9 RUFY1 EEF1B2 MTOR CTNNA1 CTNNB1 IKBKB SNRNP200 PRAME FAM83A | 1.73e-04 | 1249 | 272 | 33 | int:BRCA1 |
| Interaction | DSCR9 interactions | 1.77e-04 | 147 | 272 | 9 | int:DSCR9 | |
| Interaction | VPS33A interactions | EIF3E BCR PIK3R4 RBSN RAB4A VPS18 NRAS CNTRL PIKFYVE HOOK3 CDK5RAP2 MYBL2 | 1.78e-04 | 253 | 272 | 12 | int:VPS33A |
| Interaction | YWHAE interactions | TANC2 DLGAP1 MYCBP2 KIAA0232 EIF3E SMC5 BCR PIK3R4 DST MAST4 PI4KB STIP1 JAKMIP1 HECTD1 SFN KRAS PPFIBP2 ARHGEF5 CHAF1A KLC4 RUFY1 PPM1B GRIP1 CCDC88C EEF1B2 MTOR SHCBP1 ERC2 SCAF11 ATIC CTNNB1 ARHGAP45 PCM1 | 1.92e-04 | 1256 | 272 | 33 | int:YWHAE |
| Interaction | ARHGEF35 interactions | 1.92e-04 | 9 | 272 | 3 | int:ARHGEF35 | |
| Interaction | SLAMF7 interactions | 1.96e-04 | 22 | 272 | 4 | int:SLAMF7 | |
| Interaction | NECTIN1 interactions | 1.96e-04 | 22 | 272 | 4 | int:NECTIN1 | |
| Interaction | CEP104 interactions | 2.03e-04 | 89 | 272 | 7 | int:CEP104 | |
| Interaction | RNH1 interactions | AARS1 PSMC2 POLA2 STIP1 SFN KRAS ERO1A HAT1 SPAG9 RUFY1 ILKAP | 2.09e-04 | 220 | 272 | 11 | int:RNH1 |
| Interaction | POLR2C interactions | CCP110 EIF3E PSMC2 POLR2M DHX15 EHBP1L1 SUPT6H STIP1 DNMT3A KRAS CNTRL CDK5RAP2 SCAF11 PCNT | 2.17e-04 | 338 | 272 | 14 | int:POLR2C |
| Interaction | ATG16L1 interactions | TANC2 CCP110 ACACB MYCBP2 LEMD3 SPEG EIF3E PSMC2 IKZF1 PHGDH ITPR2 RBSN GLG1 GCN1 KRAS TUT7 CNTRL RAB3D RUFY1 WDR26 DIS3 PDHX PIKFYVE ARHGEF40 SHCBP1 ITSN2 CDK5RAP2 CTNNA1 LYN ARHGAP45 PCM1 | 2.30e-04 | 1161 | 272 | 31 | int:ATG16L1 |
| Interaction | HUWE1 interactions | DLGAP1 AARS1 ACACB MYCBP2 SPTB EIF3E PSMC2 PHGDH DHX15 URB1 ODR4 STIP1 HECTD1 GCN1 TARS1 RAD51D KRAS CIP2A CHAF1A SPAG9 HEATR1 RUFY1 WDR26 DIS3 EEF1B2 HOOK3 CTNNB1 LAS1L SNRNP200 PCNT | 2.37e-04 | 1110 | 272 | 30 | int:HUWE1 |
| Interaction | RAB5A interactions | PDXDC1 LEMD3 RAB22A EIF3E ITGA2 DMXL1 PIK3R4 RBSN PTPN12 DST GLG1 PI4KB HRAS HERC2 RAB4A VPS18 RUFY1 PPM1B PIKFYVE CCDC88C RDH11 UNC5C | 2.51e-04 | 706 | 272 | 22 | int:RAB5A |
| Interaction | SORBS1 interactions | 2.68e-04 | 123 | 272 | 8 | int:SORBS1 | |
| Interaction | TRPV2 interactions | 2.72e-04 | 10 | 272 | 3 | int:TRPV2 | |
| Interaction | ZBTB12 interactions | 2.72e-04 | 10 | 272 | 3 | int:ZBTB12 | |
| Interaction | ERBIN interactions | DLGAP1 BCR DST HRAS PICK1 SFN KRAS NRAS CTNNA1 CTNNB1 LYN MUSK | 2.72e-04 | 265 | 272 | 12 | int:ERBIN |
| Interaction | PPFIBP2 interactions | 2.73e-04 | 43 | 272 | 5 | int:PPFIBP2 | |
| Interaction | GRIA3 interactions | 2.73e-04 | 43 | 272 | 5 | int:GRIA3 | |
| Interaction | CTNNA1 interactions | POLA2 BCR KIDINS220 HRAS STIP1 HERC2 KRAS CHAF1A TFCP2 CCDC88C CTNNA3 CTNNA1 CTNNB1 LYN | 2.83e-04 | 347 | 272 | 14 | int:CTNNA1 |
| Interaction | EIF4G1 interactions | RPS6 EIF3E PSMC2 SMC5 POLA2 ITPR2 STIP1 HERC2 HECTD1 TARS1 SFN KRAS VPS18 HAT1 SPAG9 ANKRD24 | 2.85e-04 | 433 | 272 | 16 | int:EIF4G1 |
| Interaction | CEP57L1 interactions | 3.03e-04 | 95 | 272 | 7 | int:CEP57L1 | |
| Interaction | RP2 interactions | 3.03e-04 | 95 | 272 | 7 | int:RP2 | |
| Interaction | SCN2B interactions | 3.03e-04 | 95 | 272 | 7 | int:SCN2B | |
| Interaction | ARHGEF10 interactions | 3.03e-04 | 95 | 272 | 7 | int:ARHGEF10 | |
| Interaction | CCDC183 interactions | 3.05e-04 | 44 | 272 | 5 | int:CCDC183 | |
| Interaction | CCDC18 interactions | 3.11e-04 | 68 | 272 | 6 | int:CCDC18 | |
| Interaction | PSMD14 interactions | PSMC2 ALDH1L1 BCR DHX15 ODR4 CARD9 SUPT6H GLG1 STIP1 HERC2 KRAS PPFIBP2 CNTRL PPM1B NLRP9 MTOR LSS PCNT | 3.13e-04 | 527 | 272 | 18 | int:PSMD14 |
| Interaction | FAM234A interactions | 3.16e-04 | 126 | 272 | 8 | int:FAM234A | |
| Interaction | PKP4 interactions | 3.18e-04 | 159 | 272 | 9 | int:PKP4 | |
| Interaction | FAM50B interactions | 3.36e-04 | 69 | 272 | 6 | int:FAM50B | |
| Interaction | EGLN3 interactions | CCP110 GALK1 MYCBP2 LEMD3 PSMC2 BCR PHGDH PIK3R4 KIDINS220 NFATC1 NFATC3 PI4KB CIAPIN1 MKLN1 STIP1 HECTD1 GCN1 TET3 TANGO6 CIP2A CPEB3 HAT1 WDR26 PPM1B CHTF18 TJAP1 CDK5RAP2 CTNNA1 CTNNB1 LAS1L IKBKB PCM1 MYBL2 | 3.38e-04 | 1296 | 272 | 33 | int:EGLN3 |
| Interaction | RGS12 interactions | 3.39e-04 | 45 | 272 | 5 | int:RGS12 | |
| Interaction | STYXL1 interactions | 3.39e-04 | 45 | 272 | 5 | int:STYXL1 | |
| Interaction | RND3 interactions | TPM1 PDXDC1 LEMD3 ITGA2 ITGA5 KIDINS220 DST SFN HEATR1 RUFY1 PDHX CTNNB1 | 3.57e-04 | 273 | 272 | 12 | int:RND3 |
| Interaction | SNAP23 interactions | CCP110 HRAS RAB4A KRAS NRAS CTNNA1 CTNNB1 IKBKB LYN SNRNP200 | 3.59e-04 | 197 | 272 | 10 | int:SNAP23 |
| Interaction | RASGRP1 interactions | 3.70e-04 | 11 | 272 | 3 | int:RASGRP1 | |
| Interaction | TACSTD2 interactions | 3.71e-04 | 129 | 272 | 8 | int:TACSTD2 | |
| Interaction | PRMT1 interactions | AARS1 SPEG RPS6 EIF3E PSMC2 PHGDH DHX15 TXNDC5 ODR4 EXOSC6 JAKMIP1 KRAS CC2D1B KRR1 SKI RNF17 RUFY1 WDR26 DIS3 PDHX PPM1B GRIP1 CCDC88C SCAF11 LYN SNRNP200 | 3.71e-04 | 929 | 272 | 26 | int:PRMT1 |
| Interaction | ISCU interactions | 3.76e-04 | 46 | 272 | 5 | int:ISCU | |
| Interaction | NEK6 interactions | 3.82e-04 | 163 | 272 | 9 | int:NEK6 | |
| Interaction | DUSP16 interactions | KIAA0232 PSMC2 POLA2 VPS18 TRIM54 HOOK3 CDK5RAP2 LAS1L SNRNP200 PCM1 PCNT | 3.96e-04 | 237 | 272 | 11 | int:DUSP16 |
| Interaction | PML interactions | ATR RPS6 EIF3E SMC5 ITPR2 DHX15 NFATC1 COG1 MLH1 GCN1 TARS1 TLK2 KRAS SPAG9 HEATR1 SKI DIS3 TFCP2 SBNO2 MTOR CHTF18 ERC2 CTNNB1 LAS1L PADI3 ILKAP | 3.96e-04 | 933 | 272 | 26 | int:PML |
| Interaction | ANKRD26 interactions | 4.11e-04 | 131 | 272 | 8 | int:ANKRD26 | |
| Interaction | NPTN interactions | ATR COG1 AP5Z1 HRAS GCN1 PICK1 CIP2A ABCB6 HEATR1 PIKFYVE MTOR PRAME | 4.20e-04 | 278 | 272 | 12 | int:NPTN |
| Interaction | VSIG1 interactions | 4.24e-04 | 72 | 272 | 6 | int:VSIG1 | |
| Interaction | PCDH7 interactions | AARS1 PDGFRB TXNDC5 HRAS STIP1 TARS1 SFN PNP KRAS TUT7 CC2D1B LYN | 4.34e-04 | 279 | 272 | 12 | int:PCDH7 |
| Interaction | DDX41 interactions | 4.36e-04 | 166 | 272 | 9 | int:DDX41 | |
| GeneFamily | Ankyrin repeat domain containing | TANC2 ANKRD30B ANKRD20A2P ANKRD20A3P KIDINS220 ANKRD20A4P ASB8 ANKRD18A HECTD1 ANKRD20A1 ANKRD30BL ANKRD35 ASB13 ANKRD30A ANKRD24 | 4.55e-08 | 242 | 191 | 15 | 403 |
| GeneFamily | Nuclear factors of activated T-cells | 5.99e-08 | 5 | 191 | 4 | 665 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.56e-07 | 66 | 191 | 8 | 722 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | PDGFRB SPEG OBSCN IGSF22 HMCN2 NRCAM KALRN UNC5C MUSK MYBPC2 | 8.35e-06 | 161 | 191 | 10 | 593 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.61e-05 | 36 | 191 | 5 | 823 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.32e-04 | 10 | 191 | 3 | 53 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 3.04e-04 | 31 | 191 | 4 | 81 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.39e-03 | 115 | 191 | 6 | 769 | |
| GeneFamily | NLR family | 2.25e-03 | 25 | 191 | 3 | 666 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_3_DN | EIF3E ITGA2 DST MAST4 PI4KB HRAS FHIP2B CHD9 HEATR1 SEC31B ARHGEF40 IKBKB | 5.68e-06 | 226 | 277 | 12 | M11238 |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP | TRADD INPP4A AP5Z1 IFI44L TARS1 KRAS DOCK10 KRR1 KDM2A LAS1L IKBKB | 1.00e-05 | 200 | 277 | 11 | M8026 |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_DN | IKZF1 ITGA2 NFATC1 MKLN1 HERC2 KRAS IFIT2 WDR26 CCDC88C ASB13 ITSN2 | 1.00e-05 | 200 | 277 | 11 | M9315 |
| Coexpression | GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP | INPP4B NFATC1 PI4KB MED12L IFI44L IDI1 IFIT2 ASB13 RSAD2 LSS LYN | 1.00e-05 | 200 | 277 | 11 | M8559 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | TANC2 AARS1 RAB22A ITGA2 SMC5 ADCY7 DST AP5Z1 MKLN1 NRAS HUS1 SPAG9 RLF RSAD2 PPP2R5B ITSN2 TJAP1 LSS KDM2A NFAT5 ARHGAP45 CXCL8 ATP6V0A2 | 2.41e-05 | 822 | 277 | 23 | M6782 |
| Coexpression | GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP | CDC14C ANKRD30B CCDC178 DMXL1 GLG1 EID1 ANKRD18A EVC2 DOCK10 ATIC | 5.47e-05 | 199 | 277 | 10 | M6218 |
| Coexpression | GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP | TPM1 RPS6 BNIP1 KIDINS220 HUS1 OGFR PIKFYVE RDH11 IKBKB PCM1 | 5.47e-05 | 199 | 277 | 10 | M5187 |
| Coexpression | GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_DN | 5.71e-05 | 200 | 277 | 10 | M7237 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP | MYCBP2 IKZF1 FYCO1 PTPN12 AFF1 CNTRL SPAG9 WDR26 SBNO2 ARHGAP45 | 5.71e-05 | 200 | 277 | 10 | M6096 |
| Coexpression | GABRIELY_MIR21_TARGETS | TPM1 MYCBP2 RAB22A SMC5 PM20D2 HECTD1 CNTRL CPEB3 DOCK10 ITSN2 SCAF11 NFAT5 | 6.46e-05 | 289 | 277 | 12 | M2196 |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN | TANC2 PGGT1B ADCY7 INPP4B EHBP1L1 MAST4 SFN PNP TANGO6 ERO1A RAB3D CC2D1B PPP2R5B FAM83A | 6.60e-05 | 384 | 277 | 14 | M12527 |
| Coexpression | FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN | 7.85e-05 | 42 | 277 | 5 | M9905 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ATR MYCBP2 EIF3E PHGDH DMXL1 ITPR2 KIDINS220 HECTD1 TUT7 DOCK10 VPS26A IDI1 KRR1 RLF ITSN2 CDK5RAP2 SCAF11 PCM1 PROS1 | 7.94e-05 | 656 | 277 | 19 | M18979 |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN | 9.05e-05 | 171 | 277 | 9 | M8820 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | KIAA0232 SMC5 PIK3R4 DST MAST4 AFF1 IFI44L TLK2 CPEB3 CHD9 PIKFYVE SCAF11 | 9.20e-05 | 300 | 277 | 12 | M8702 |
| Coexpression | PARK_HSC_MARKERS | 9.86e-05 | 44 | 277 | 5 | M6509 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CCP110 DDX59 ATR BACH2 EIF3E SMC5 ME2 PTPN12 EML5 PI4KB DIAPH2 MLH1 STIP1 DSCC1 FHIP2B TLK2 KRAS PDZD9 NRCAM CIP2A CNTRL HAT1 CHD9 HEATR1 IDI1 CCDC88C ASB13 HOOK3 LMX1B CHTF18 RPUSD2 LSS SCAF11 PCM1 MYBL2 | 1.10e-05 | 1257 | 270 | 35 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | TPM1 PDGFRB SPTB TRPC6 OBSCN ADCY5 INPP4B AFAP1L2 DST PDZRN4 KRT78 NRCAM LZTS1 UNC5C | 3.38e-11 | 199 | 278 | 14 | 854628ce91068093c14bd4d45ba38c41469f3549 |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | TPM1 PDGFRB TRPC6 OBSCN ADCY5 INPP4B AFAP1L2 DST PDZRN4 KRT78 NRCAM LZTS1 UNC5C | 4.30e-10 | 199 | 278 | 13 | 929f809579368201331d9099d8904b6e3c41797b |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | TPM1 PDGFRB SPTB TRPC6 OBSCN ADCY5 INPP4B AFAP1L2 PDZRN4 NRCAM LZTS1 UNC5C | 1.95e-09 | 183 | 278 | 12 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | TPM1 PDGFRB SPTB TRPC6 OBSCN ADCY5 INPP4B AFAP1L2 PDZRN4 NRCAM LZTS1 UNC5C | 2.49e-09 | 187 | 278 | 12 | 62759efb660179402fb574ce5701c89a2e17bcfe |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | TPM1 PDGFRB SPEG ITGA5 ADCY5 INPP4B EHBP1L1 PDZRN4 KALRN ZSCAN5B UNC5C CDH13 | 4.76e-09 | 198 | 278 | 12 | bd42c03e384e64f61b02618cf1a5440033bb04b2 |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | TPM1 PDGFRB SPEG ITGA5 ADCY5 INPP4B EHBP1L1 PDZRN4 KALRN ZSCAN5B UNC5C CDH13 | 5.04e-09 | 199 | 278 | 12 | b1753474152b82a0b811b9878c890a359e14919a |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | TPM1 PDGFRB SPEG SPTB TRPC6 ADCY5 INPP4B PDZRN4 KALRN UNC5C CDH13 | 1.20e-08 | 172 | 278 | 11 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | TPM1 PDGFRB SPTB TRPC6 OBSCN ADCY5 INPP4B AFAP1L2 NRCAM LZTS1 UNC5C | 1.72e-08 | 178 | 278 | 11 | 185b44700f06ec58b3c09c80520502166c965fd6 |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | TPM1 PDGFRB SPEG ITGA5 ADCY5 INPP4B TLN2 PDZRN4 KALRN UNC5C CDH13 | 1.93e-08 | 180 | 278 | 11 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | TPM1 PDGFRB SPEG SPTB TRPC6 ADCY5 INPP4B KALRN LZTS1 CTNNA3 CDH13 | 3.55e-08 | 191 | 278 | 11 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | TPM1 PDGFRB SPEG TRPC6 ADCY5 INPP4B AFAP1L2 PDZRN4 LZTS1 UNC5C CDH13 | 4.17e-08 | 194 | 278 | 11 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TANC2 DST MED12L HERC2 MYO18B PNP CHD9 SKI ARHGEF40 SCAF11 PROS1 | 4.39e-08 | 195 | 278 | 11 | a1478021a3ed0e779716393124ca2a7770c433b7 |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | TPM1 PDGFRB SPEG ITGA5 ADCY5 INPP4B HMCN2 PDZRN4 KALRN UNC5C CDH13 | 4.88e-08 | 197 | 278 | 11 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TPM1 PDGFRB TRPC6 ADCY5 AFAP1L2 MED12L PPFIBP2 LZTS1 CTNNA3 ERC2 | 5.48e-08 | 156 | 278 | 10 | 6365b69ede98bc866e996bc52736b00401aacf6f |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.04e-07 | 167 | 278 | 10 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-07 | 173 | 278 | 10 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DIAPH2 TUT7 CNTRL SPAG9 IFIT2 CCDC88C RSAD2 ITSN2 SCAF11 PCM1 | 1.89e-07 | 178 | 278 | 10 | 01dafd19de04eff459253eaa9a35debf8f3deedf |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-5|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.32e-07 | 182 | 278 | 10 | 9e48d5b634603bc7a8d29290202a311457678328 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.57e-07 | 184 | 278 | 10 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | TPM1 SPTB OBSCN ADCY5 INPP4B MYO18B TRIM54 LMOD2 CTNNA3 CDH13 | 2.70e-07 | 185 | 278 | 10 | 549eeb521c3985bff396ea0f202db21822efa51f |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TPM1 PDGFRB SPEG TRPC6 ADCY5 INPP4B PDZRN4 KALRN PPFIBP2 CTNNA3 | 2.84e-07 | 186 | 278 | 10 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | TPM1 PDGFRB TRPC6 OBSCN ADCY5 INPP4B AFAP1L2 NRCAM LZTS1 UNC5C | 3.13e-07 | 188 | 278 | 10 | ee151792c7ac9afe820f1a281c6dab383799f358 |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.17e-07 | 144 | 278 | 9 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | TPM1 PDGFRB TRPC6 OBSCN ADCY5 INPP4B AFAP1L2 NRCAM LZTS1 UNC5C | 3.45e-07 | 190 | 278 | 10 | 4eb92aef1ee868f4537483d19014d947b7684612 |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | TPM1 PDGFRB TRPC6 OBSCN ADCY5 INPP4B AFAP1L2 NRCAM LZTS1 UNC5C | 3.45e-07 | 190 | 278 | 10 | 7be4341e2909101d756f14031c21e705eb45e69a |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PDGFRB SPEG ADCY5 INPP4B PDZRN4 KALRN LZTS1 UNC5C CTNNA3 CDH13 | 3.62e-07 | 191 | 278 | 10 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ARMC3 ITGA2 STOX1 EFHB TRMT9B GRM7 CCDC39 GSTM2 HYDIN CFAP46 | 3.99e-07 | 193 | 278 | 10 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | TPM1 PDGFRB TRPC6 OBSCN ADCY5 INPP4B AFAP1L2 NRCAM LZTS1 UNC5C | 4.18e-07 | 194 | 278 | 10 | 2d66091097e106c7bee22e5281f50724700bdf8d |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRB TRPC6 OBSCN ADCY5 INPP4B AFAP1L2 PDZRN4 NRCAM LZTS1 UNC5C | 4.82e-07 | 197 | 278 | 10 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRB TRPC6 OBSCN ADCY5 INPP4B AFAP1L2 PDZRN4 NRCAM LZTS1 UNC5C | 4.82e-07 | 197 | 278 | 10 | f66945f9007d59d4208849c7fd727f8519713fbc |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | TPM1 PDGFRB SPEG ADCY5 INPP4B HMCN2 PDZRN4 KALRN CTNNA3 CDH13 | 5.53e-07 | 200 | 278 | 10 | a66449b22b39dd6987fc2c3ed160d24564234ced |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.41e-06 | 172 | 278 | 9 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.48e-06 | 173 | 278 | 9 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.48e-06 | 173 | 278 | 9 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 1.62e-06 | 175 | 278 | 9 | 35ea2ed93538e6bf803029fcf7d9243f93e7733d | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.70e-06 | 176 | 278 | 9 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|COVID-19_Severe / Disease condition and Cell class | 2.15e-06 | 181 | 278 | 9 | 0d07a67e8ee3bca687b378afbc4044434e63556d | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.15e-06 | 181 | 278 | 9 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 2.25e-06 | 182 | 278 | 9 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 2.35e-06 | 183 | 278 | 9 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-06 | 183 | 278 | 9 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAM184B PDGFRB TRPC6 ADCY5 INPP4B AFAP1L2 CCL28 KALRN CTNNA3 | 2.35e-06 | 183 | 278 | 9 | 421265fa15d5a028cb567bb0904e670473ef102b |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAM184B PDGFRB TRPC6 ADCY5 INPP4B AFAP1L2 CCL28 KALRN CTNNA3 | 2.35e-06 | 183 | 278 | 9 | 8d45dff06a199b1369576657f7f9dc0249c5f841 |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.35e-06 | 183 | 278 | 9 | 523896bd1a93bdda81a009768baa3a1bdbd108b8 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-06 | 184 | 278 | 9 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P BCR DST ANKRD20A4P MED12L ANKRD20A1 ATP6V0A2 | 2.46e-06 | 184 | 278 | 9 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-06 | 184 | 278 | 9 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-06 | 185 | 278 | 9 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-06 | 186 | 278 | 9 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-06 | 186 | 278 | 9 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.80e-06 | 187 | 278 | 9 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.80e-06 | 187 | 278 | 9 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-06 | 189 | 278 | 9 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-06 | 189 | 278 | 9 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 3.06e-06 | 189 | 278 | 9 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.20e-06 | 190 | 278 | 9 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 3.34e-06 | 191 | 278 | 9 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-06 | 192 | 278 | 9 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-06 | 192 | 278 | 9 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-06 | 144 | 278 | 8 | 1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.79e-06 | 194 | 278 | 9 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-06 | 194 | 278 | 9 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 3.79e-06 | 194 | 278 | 9 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-06 | 194 | 278 | 9 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.79e-06 | 194 | 278 | 9 | 216cba1a04b1a24b080322bc950e7fa2dade5ff1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-06 | 194 | 278 | 9 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.95e-06 | 195 | 278 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 3.95e-06 | 195 | 278 | 9 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.12e-06 | 196 | 278 | 9 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-06 | 196 | 278 | 9 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.29e-06 | 197 | 278 | 9 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | mild-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.29e-06 | 197 | 278 | 9 | 21085d5e27b5a23a241a933058bb89f8a1fcf198 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-06 | 197 | 278 | 9 | d9978aaa476b57144b0561f535ff1dd886c7512b | |
| ToppCell | (1)_T_cell-(16)_Tfh|(1)_T_cell / shred on Cell_type and subtype | 4.85e-06 | 200 | 278 | 9 | 3b28137e8e69b98fde9f6ab8320cb4d1c3543ef9 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.85e-06 | 200 | 278 | 9 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 4.85e-06 | 200 | 278 | 9 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.85e-06 | 200 | 278 | 9 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.85e-06 | 200 | 278 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.85e-06 | 200 | 278 | 9 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_T_naive|Control / Disease, condition lineage and cell class | 4.85e-06 | 200 | 278 | 9 | 906de95adc9716982ab32f216dddeb52639bad06 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.85e-06 | 200 | 278 | 9 | f11ae9055e72c938b6c9e52701478b2eee681ac4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.63e-06 | 157 | 278 | 8 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-06 | 158 | 278 | 8 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.95e-06 | 158 | 278 | 8 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | lymphoid-T_cell-pro-T_cell|T_cell / Lineage, cell class and subclass | 7.62e-06 | 160 | 278 | 8 | 66fe86d2f37983761141e5bb3de127f0b4bb0951 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.98e-06 | 161 | 278 | 8 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.73e-06 | 163 | 278 | 8 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 9.13e-06 | 164 | 278 | 8 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| ToppCell | Control-Lymphoid_T/NK-CD4+_T_activated|Control / Disease group, lineage and cell class | 9.90e-06 | 119 | 278 | 7 | d7352d0dafbb664619b7a1e3cd07b159fdfec197 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-05 | 169 | 278 | 8 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.24e-05 | 171 | 278 | 8 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.35e-05 | 173 | 278 | 8 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.46e-05 | 175 | 278 | 8 | 2812ac2ef41d245db544697fb6da1883361c96e8 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-05 | 175 | 278 | 8 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-05 | 175 | 278 | 8 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 175 | 278 | 8 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 175 | 278 | 8 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 175 | 278 | 8 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-erythroid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.59e-05 | 177 | 278 | 8 | b647667da62a91dbe3890820142626e26aa779d2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-05 | 179 | 278 | 8 | dc6cd46fa652b296ddbc41855f6377946d0a4cdc | |
| Drug | NSC92228 | 1.80e-06 | 3 | 278 | 3 | CID000017897 | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; HL60; HG-U133A | TRADD ATR BNIP1 HRAS AFF1 OGFR CHAF1A CCDC88C MTOR TJAP1 SCAF11 CXCL8 | 5.63e-06 | 196 | 278 | 12 | 1569_DN |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HG-U133A | BNIP1 NFATC1 NFATC4 FBXO41 ERO1A TUT7 TFCP2 ARHGEF40 LZTS1 CDK5RAP2 NFAT5 MYBL2 | 5.93e-06 | 197 | 278 | 12 | 224_DN |
| Drug | AC1L1XPX | 6.24e-06 | 38 | 278 | 6 | CID000011606 | |
| Drug | SC 19220; Down 200; 10uM; PC3; HT_HG-U133A | CCP110 TRADD MAST4 CIAPIN1 NPR2 HUS1 IFIT2 PPP2R5B RPUSD2 NFAT5 PCM1 ATP6V0A2 | 6.24e-06 | 198 | 278 | 12 | 7095_DN |
| Drug | L 744832 | 7.14e-06 | 4 | 278 | 3 | ctd:C096898 | |
| Drug | wartmannin | PDGFRB RPS6 TRPC6 ITGA2 ITGA5 EPX PIK3R4 PI4KB HRAS MLH1 MYO18B RAB4A VPS18 RAB3D VPS26A RUFY1 PIKFYVE PTPA MTOR CDK5RAP2 ATIC CTNNB1 IKBKB LYN NFAT5 CXCL8 | 7.91e-06 | 811 | 278 | 26 | CID000005691 |
| Drug | Methamphetamine | GALK1 ACACB SPEG RPS6 BACH2 OBSCN POLA2 PHGDH ITPR2 LDHD EHBP1L1 DST APEX2 NFATC3 NFATC4 SUPT6H HRAS ASTN2 STIP1 HERC2 MYO18B PICK1 EVC2 CPEB3 RAB3D CC2D1B SPAG9 DIS3 RLF MTOR CHTF18 SHCBP1 TJAP1 CTNNB1 NFAT5 CDH13 PCNT | 8.20e-06 | 1401 | 278 | 37 | ctd:D008694 |
| Disease | Hemimegalencephaly | 9.41e-08 | 6 | 265 | 4 | C0431391 | |
| Disease | Colorectal Carcinoma | MCF2L2 OBSCN ALDH1L1 NFATC1 MLH1 JAKMIP1 ABCD2 PDZRN4 KRAS DPAGT1 VPS18 EVC2 NRAS NRCAM KALRN HAT1 ABCB6 KDM2A CTNNB1 LAS1L SNRNP200 CXCL8 PROS1 | 1.14e-07 | 702 | 265 | 23 | C0009402 |
| Disease | colorectal cancer (implicated_via_orthology) | 2.46e-07 | 30 | 265 | 6 | DOID:9256 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | DDX59 RPS6 MCF2L2 OBSCN PHGDH INPP4B PIK3R4 HRAS AFF1 ASTN2 HERC2 DNMT3A KRAS DPAGT1 NRCAM KALRN ABCB6 RUFY1 EEF1B2 NLRP9 HOOK3 MTOR ITSN2 ANKRD30A CTNNB1 IKBKB PADI3 CXCL8 | 5.09e-07 | 1074 | 265 | 28 | C0006142 |
| Disease | Verrucous epidermal nevus | 7.16e-07 | 3 | 265 | 3 | C0362030 | |
| Disease | Nevus Sebaceus of Jadassohn | 7.16e-07 | 3 | 265 | 3 | C4552097 | |
| Disease | Linear nevus sebaceous syndrome | 7.16e-07 | 3 | 265 | 3 | cv:C4552097 | |
| Disease | Nevus sebaceous | 7.16e-07 | 3 | 265 | 3 | C3854181 | |
| Disease | Inflammatory linear verrucous epidermal nevus | 7.16e-07 | 3 | 265 | 3 | C0473574 | |
| Disease | SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME | 7.16e-07 | 3 | 265 | 3 | 163200 | |
| Disease | linear nevus sebaceous syndrome (is_implicated_in) | 7.16e-07 | 3 | 265 | 3 | DOID:0111530 (is_implicated_in) | |
| Disease | Linear Verrucous Epidermal Nevus | 7.16e-07 | 3 | 265 | 3 | C3179502 | |
| Disease | cervical cancer (implicated_via_orthology) | 7.16e-07 | 3 | 265 | 3 | DOID:4362 (implicated_via_orthology) | |
| Disease | Organoid Nevus Phakomatosis | 7.16e-07 | 3 | 265 | 3 | C0265329 | |
| Disease | Noonan syndrome 3 (implicated_via_orthology) | 7.16e-07 | 3 | 265 | 3 | DOID:0060581 (implicated_via_orthology) | |
| Disease | Gastric Adenocarcinoma | 3.01e-06 | 45 | 265 | 6 | C0278701 | |
| Disease | Intellectual Disability | TANC2 UBA5 PDGFRB INPP4A BRWD3 MED12L TET3 DNMT3A TLK2 WDR26 PDHX EEF1B2 MTOR LSS ATIC LAS1L | 3.37e-06 | 447 | 265 | 16 | C3714756 |
| Disease | cancer (implicated_via_orthology) | PSMC2 DST HRAS FGR KRAS NRAS IDI1 PPP2R5B MTOR COASY CTNNB1 LYN | 6.29e-06 | 268 | 265 | 12 | DOID:162 (implicated_via_orthology) |
| Disease | NEVUS, EPIDERMAL (disorder) | 7.07e-06 | 5 | 265 | 3 | C0334082 | |
| Disease | Follicular thyroid carcinoma | 7.07e-06 | 5 | 265 | 3 | C0206682 | |
| Disease | lung carcinoma (implicated_via_orthology) | 7.07e-06 | 5 | 265 | 3 | DOID:3905 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 9.29e-06 | 32 | 265 | 5 | DOID:10155 (implicated_via_orthology) | |
| Disease | prostate cancer (implicated_via_orthology) | 1.09e-05 | 33 | 265 | 5 | DOID:10283 (implicated_via_orthology) | |
| Disease | Acute Myeloid Leukemia, M1 | 1.81e-05 | 125 | 265 | 8 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.81e-05 | 125 | 265 | 8 | C1879321 | |
| Disease | Malignant Neoplasms | 2.15e-05 | 128 | 265 | 8 | C0006826 | |
| Disease | Ulcerative Colitis | 2.19e-05 | 63 | 265 | 6 | C0009324 | |
| Disease | carcinoma (implicated_via_orthology) | 2.40e-05 | 64 | 265 | 6 | DOID:305 (implicated_via_orthology) | |
| Disease | Leukemia, Myelocytic, Acute | 2.85e-05 | 173 | 265 | 9 | C0023467 | |
| Disease | Thyroid carcinoma | 4.59e-05 | 44 | 265 | 5 | C0549473 | |
| Disease | RASopathy (implicated_via_orthology) | 5.78e-05 | 9 | 265 | 3 | DOID:0080690 (implicated_via_orthology) | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 8.04e-05 | 2 | 265 | 2 | 614470 | |
| Disease | MELANOCYTIC NEVUS SYNDROME, CONGENITAL | 8.04e-05 | 2 | 265 | 2 | 137550 | |
| Disease | Melanocytic nevus | 8.04e-05 | 2 | 265 | 2 | cv:C0027962 | |
| Disease | Large congenital melanocytic nevus | 8.04e-05 | 2 | 265 | 2 | cv:C1842036 | |
| Disease | Autoimmune lymphoproliferative syndrome type 4 | 8.04e-05 | 2 | 265 | 2 | cv:C2674723 | |
| Disease | autoimmune lymphoproliferative syndrome type 4 (is_implicated_in) | 8.04e-05 | 2 | 265 | 2 | DOID:0110117 (is_implicated_in) | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 8.04e-05 | 2 | 265 | 2 | C2674723 | |
| Disease | large congenital melanocytic nevus (is_implicated_in) | 8.04e-05 | 2 | 265 | 2 | DOID:0111359 (is_implicated_in) | |
| Disease | Non-Small Cell Lung Carcinoma | 8.79e-05 | 156 | 265 | 8 | C0007131 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.10e-04 | 206 | 265 | 9 | C0152013 | |
| Disease | Noonan Syndrome 1 | 1.12e-04 | 11 | 265 | 3 | C4551602 | |
| Disease | Turner Syndrome, Male | 1.12e-04 | 11 | 265 | 3 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 1.12e-04 | 11 | 265 | 3 | C1527404 | |
| Disease | kidney cancer (implicated_via_orthology) | 1.12e-04 | 11 | 265 | 3 | DOID:263 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 1.27e-04 | 29 | 265 | 4 | C0496920 | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 1.36e-04 | 55 | 265 | 5 | DOID:9952 (is_implicated_in) | |
| Disease | Ovarian Carcinoma | 1.45e-04 | 30 | 265 | 4 | C0029925 | |
| Disease | PR interval | MYCBP2 OBSCN ALDH1L1 ADCY5 PRPS1L1 BNIP1 MKLN1 AFF1 ASTN2 KALRN SKI ARHGEF40 TJAP1 CDH13 | 1.73e-04 | 495 | 265 | 14 | EFO_0004462 |
| Disease | Squamous cell carcinoma of lung | 1.88e-04 | 32 | 265 | 4 | C0149782 | |
| Disease | middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement | 1.92e-04 | 13 | 265 | 3 | EFO_0006514, EFO_0010316 | |
| Disease | ovarian neoplasm | 2.17e-04 | 134 | 265 | 7 | C0919267 | |
| Disease | Colorectal Neoplasms | 2.20e-04 | 277 | 265 | 10 | C0009404 | |
| Disease | Seckel syndrome 1 | 2.40e-04 | 3 | 265 | 2 | C4551474 | |
| Disease | GIANT PIGMENTED HAIRY NEVUS | 2.40e-04 | 3 | 265 | 2 | C1842036 | |
| Disease | Malignant neoplasm of ovary | 2.48e-04 | 137 | 265 | 7 | C1140680 | |
| Disease | Uterine Cervical Neoplasm | 2.67e-04 | 35 | 265 | 4 | C0007873 | |
| Disease | RASopathy | 3.01e-04 | 15 | 265 | 3 | cv:C5555857 | |
| Disease | Thyroid Neoplasm | 3.33e-04 | 37 | 265 | 4 | C0040136 | |
| Disease | Major Depressive Disorder | 3.76e-04 | 243 | 265 | 9 | C1269683 | |
| Disease | Nonorganic psychosis | 3.96e-04 | 69 | 265 | 5 | C0349204 | |
| Disease | Malignant neoplasm of stomach | 4.14e-04 | 300 | 265 | 10 | C0024623 | |
| Disease | Schizophrenia | DLGAP1 PDGFRB ME2 ADCY7 KCNH6 TXNDC5 EML5 ASTN2 PICK1 GRM7 LMOD2 SBNO2 GSTM2 LMX1B MTOR UNC5C CTNNB1 PCM1 PCNT | 4.35e-04 | 883 | 265 | 19 | C0036341 |
| Disease | Lymphoma | 4.51e-04 | 40 | 265 | 4 | C0024299 | |
| Disease | valine measurement | 4.51e-04 | 40 | 265 | 4 | EFO_0009792 | |
| Disease | Malignant neoplasm of penis | 4.76e-04 | 4 | 265 | 2 | C0153601 | |
| Disease | Penile Neoplasms | 4.76e-04 | 4 | 265 | 2 | C0030849 | |
| Disease | BLADDER CANCER | 4.76e-04 | 4 | 265 | 2 | 109800 | |
| Disease | Epidermal nevus | 4.76e-04 | 4 | 265 | 2 | cv:C0334082 | |
| Disease | Malignant tumor of urinary bladder | 4.76e-04 | 4 | 265 | 2 | cv:C0005684 | |
| Disease | Malignant tumor of cervix | 4.76e-04 | 4 | 265 | 2 | C0007847 | |
| Disease | Malignant neoplasm of cecum | 4.76e-04 | 4 | 265 | 2 | C0153437 | |
| Disease | epidermal nevus (is_implicated_in) | 4.76e-04 | 4 | 265 | 2 | DOID:0111162 (is_implicated_in) | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 4.76e-04 | 4 | 265 | 2 | 188470 | |
| Disease | fasting blood glucose measurement, response to metformin | 4.76e-04 | 4 | 265 | 2 | EFO_0004465, GO_1901558 | |
| Disease | NEVUS, EPIDERMAL | 4.76e-04 | 4 | 265 | 2 | 162900 | |
| Disease | purine-pyrimidine metabolic disorder (is_implicated_in) | 4.76e-04 | 4 | 265 | 2 | DOID:653 (is_implicated_in) | |
| Disease | Nevus, Keratinocytic, Nonepidermolytic | 4.76e-04 | 4 | 265 | 2 | C4011754 | |
| Disease | Transitional cell carcinoma of bladder | 4.76e-04 | 4 | 265 | 2 | C0279680 | |
| Disease | Cecal Neoplasms | 4.76e-04 | 4 | 265 | 2 | C0007528 | |
| Disease | Thyroid cancer, nonmedullary, 2 | 4.76e-04 | 4 | 265 | 2 | cv:C4225426 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 4.96e-04 | 41 | 265 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 4.96e-04 | 41 | 265 | 4 | C0858252 | |
| Disease | Malignant neoplasm of endometrium | 5.29e-04 | 18 | 265 | 3 | C0007103 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 5.29e-04 | 18 | 265 | 3 | OBA_2045065 | |
| Disease | Carcinoma in situ of endometrium | 5.29e-04 | 18 | 265 | 3 | C0346191 | |
| Disease | Hemangiosarcoma | 5.29e-04 | 18 | 265 | 3 | C0018923 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 6.24e-04 | 19 | 265 | 3 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 6.24e-04 | 19 | 265 | 3 | C1843181 | |
| Disease | Juvenile Myelomonocytic Leukemia | 6.24e-04 | 19 | 265 | 3 | C0349639 | |
| Disease | age at onset, smoking initiation | 6.24e-04 | 19 | 265 | 3 | EFO_0004847, EFO_0005670 | |
| Disease | Cardio-facio-cutaneous syndrome | 6.24e-04 | 19 | 265 | 3 | C1275081 | |
| Disease | Costello syndrome (disorder) | 6.24e-04 | 19 | 265 | 3 | C0587248 | |
| Disease | hydrocephalus (implicated_via_orthology) | 6.24e-04 | 19 | 265 | 3 | DOID:10908 (implicated_via_orthology) | |
| Disease | leukemia (implicated_via_orthology) | 6.24e-04 | 19 | 265 | 3 | DOID:1240 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of thyroid | 7.89e-04 | 5 | 265 | 2 | C0007115 | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 7.89e-04 | 5 | 265 | 2 | C4225426 | |
| Disease | 1-palmitoyl-2-dihomo-linolenoyl-GPC (16:0/20:3n3 or 6) measurement | 7.89e-04 | 5 | 265 | 2 | EFO_0800407 | |
| Disease | Cetuximab response | 7.89e-04 | 5 | 265 | 2 | cv:CN077967 | |
| Disease | Cervix carcinoma | 7.89e-04 | 5 | 265 | 2 | C0302592 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AVKGDAAEVERCLAR | 41 | Q5TYW2 | |
| EVKRAALNELVECVG | 101 | Q15173 | |
| LECVEVISEKRLQGE | 316 | Q68DN1 | |
| GVLAALCEKTDNDIR | 536 | Q8WVB6 | |
| LEALCKQEGELDRRS | 416 | Q9BYV9 | |
| IQRADGDCDLAAVIL | 51 | Q9NRJ3 | |
| AEGKDVLLLACNISE | 46 | O75871 | |
| EALRLGETEVTEKCN | 1626 | Q7Z7A1 | |
| EERDLVLTIAQCGLD | 151 | Q96FG2 | |
| VEAVRGCEIDLKEQG | 1256 | Q8TER5 | |
| VRCEALTGELETLKE | 181 | Q8N998 | |
| LTGELETLKERCAQD | 186 | Q8N998 | |
| AAIKGDAAEVERCLT | 41 | Q8IVF6 | |
| IHRDCLENGKEDLLE | 576 | Q8IVF6 | |
| AVKGDAAEVERCLAR | 41 | Q5CZ79 | |
| CERGRELKKDNCEQI | 956 | Q9BXX2 | |
| DKLELQECLEHGRIA | 811 | Q9Y6K1 | |
| RLNELCKILGEDSVL | 716 | Q9UBJ2 | |
| EKGEELSCEERNLLS | 31 | P31947 | |
| RSVGDIEQELERCKA | 26 | P11274 | |
| AVKGDAAEVERCLAR | 41 | Q4UJ75 | |
| LREDVCADGLLGEEQ | 246 | Q12774 | |
| ECVRLLIDVGANLEA | 131 | Q8WXK3 | |
| SLEQKLKEIDEECRG | 711 | Q8N4X5 | |
| LREDVCADGLLGEEQ | 246 | A5YM69 | |
| FLVDRKCQLDVLDGE | 91 | Q9BXX3 | |
| DDGLLEIERKFIDCG | 1761 | Q8IYW2 | |
| CGLAEELEKEKSREQ | 251 | Q6FI81 | |
| ADQILVIKDGCIVER | 791 | Q9NP58 | |
| QEECRTAKGDIEISL | 746 | Q6RI45 | |
| KNRCLSIGIQVDDAE | 646 | O14490 | |
| EIDCLINDEHTIKGR | 106 | O94923 | |
| KDALDELGCFQLELR | 1006 | P20594 | |
| GDSDLQKACLVEAVL | 316 | O43299 | |
| ILACEKGSAEVAELL | 191 | Q8N283 | |
| EVEKCLVALLGSEND | 316 | Q5W041 | |
| ELCRLGALDILEEVN | 516 | Q5W041 | |
| DVNKEGLECLRLLNE | 896 | P51828 | |
| ELEANNEGVECLRLL | 1086 | O95622 | |
| NCAAVAVGRILDELD | 26 | Q9UBZ4 | |
| AVGRILDELDADIVC | 31 | Q9UBZ4 | |
| REAAAELEAALGKCE | 741 | Q8TF21 | |
| EVCDDAKNLSVVILG | 591 | P55290 | |
| VICSDKADLDLRLVG | 466 | Q9NR16 | |
| AADRDCAGDDLKVLQ | 691 | Q13111 | |
| AICIVGEENILDKLL | 281 | O60879 | |
| LTGQEEIDEACKRIK | 356 | O43143 | |
| VQRLKEECEAGSREL | 161 | Q9H257 | |
| VKRFLDICENAEGAI | 266 | A4D256 | |
| CLRDAIEVCLEKLND | 1706 | Q9Y485 | |
| DDQLISGVEIRCEEK | 966 | O75129 | |
| KGDCTIRDLRNEVEK | 431 | Q96SN8 | |
| KRDGDIDNCALELAR | 236 | Q9UFE4 | |
| KEELQREGDCLDAKI | 671 | Q9UFE4 | |
| RKQVVIDGETCLLDI | 41 | P01112 | |
| LVSADLEEVAQKCGL | 31 | O75771 | |
| RKQVVIDGETCLLDI | 41 | P01116 | |
| RKQVVIDGETCLLDI | 41 | P01111 | |
| EDAELLLVGNKLDCE | 146 | Q6IQ22 | |
| LLVGNKLDCETDREI | 151 | Q6IQ22 | |
| IVVAIAGNKCDLIDV | 111 | Q9UL26 | |
| EEVELCRVSSQEKLG | 401 | Q6ZMN7 | |
| FDAKQCGRLDEVEVL | 751 | Q9H1K0 | |
| ILVGNKCDLEDERVV | 131 | O95716 | |
| IILCGNKKDLDADRE | 121 | P20338 | |
| EELCSQVNEGVREKE | 1386 | Q9NZM3 | |
| QCLLDKEGASELVID | 1746 | Q14571 | |
| QFVKLLLEEDAARVC | 261 | Q96PE3 | |
| LTCEKDVLQGELEAV | 441 | O60271 | |
| IQEAILEKCSDNDGI | 806 | Q9Y2U8 | |
| AVKGDAAEVERCLAR | 41 | Q5SQ80 | |
| VLEAGCVVARLELDD | 951 | O00763 | |
| ADCVELLLEKGAEVN | 66 | Q9H765 | |
| RQGKLEAAETLEECA | 476 | Q9NSK0 | |
| DAKQCLEIGRDTLRD | 46 | A6NGU5 | |
| GVLCELAQDKEAAEA | 616 | P35222 | |
| ALELRDGEKVLDLCA | 126 | Q9H649 | |
| VIIDGLDACEQDKVL | 771 | Q9ULH0 | |
| FAEGLEKLKECVLRD | 126 | Q92619 | |
| LLEKRQAEIEAERCG | 531 | Q86YW9 | |
| CSIQELEQKLLEREG | 261 | Q9Y250 | |
| RTKGLELEVCENELQ | 441 | Q9Y250 | |
| IRGFNEEEIKVCLEQ | 286 | Q7RTR2 | |
| ANILVGERLACKIAD | 386 | P09769 | |
| VELCGRENEVKLLVE | 521 | O14920 | |
| EVLLIQEAKRECRGS | 56 | Q6ZVK8 | |
| EALQREVKEEAGLHC | 86 | Q6ZVK8 | |
| EELRGNVLSLECIAE | 281 | Q92823 | |
| LDVEENLTAGKAEIC | 1691 | Q6PRD1 | |
| ELLVGCIAELREADE | 136 | Q86Y97 | |
| KIGNEESDLEEACIL | 1571 | O95714 | |
| DSVICEDKLILAGNA | 396 | Q03001 | |
| GCEERELALALQEAL | 116 | Q5RKV6 | |
| ILQSKEGECQQLREE | 701 | Q9BQS8 | |
| AELGIQVCALTVEKE | 906 | Q9BQS8 | |
| RVLKVLVGEALDLNC | 1171 | Q8NDA2 | |
| LECEVFRVEGIKDNL | 151 | Q53G44 | |
| DLCRNQEIKELGELS | 276 | O15327 | |
| FELDIRVEIDSGKCV | 3791 | Q2LD37 | |
| TKARLLQEQGCAEEE | 81 | Q9ULE4 | |
| RLAQALLGAEECKVD | 81 | Q9H252 | |
| LEKERLGECGKVAED | 81 | Q6P5Q4 | |
| VDCKLGADLLSEAVQ | 451 | Q5T1V6 | |
| CELLSRLKGNLEEEN | 1321 | Q9P219 | |
| EEALEACENARLKAQ | 306 | Q5BJE1 | |
| AVDKCQSREGVDIAL | 451 | Q86YR7 | |
| VNRLTEELGCDEIID | 171 | Q9Y6B2 | |
| IVFNLVELEGDCRDD | 206 | Q9H3H5 | |
| LIQERLAEEDCIKQG | 121 | Q96MA6 | |
| KDCGEDLLVEISEVL | 1666 | Q15154 | |
| QGVVVLEEFCKELAA | 706 | Q86V87 | |
| GIETLVEELCSRLKD | 126 | Q92628 | |
| DCDLGAVLKVRQDLV | 306 | O00330 | |
| LINGQVKDEDCDLLE | 221 | Q5SWX8 | |
| LEDCAQVEEGKAQLV | 246 | Q8IXQ8 | |
| LRDCIAEAKLLVDAA | 36 | P11678 | |
| RGEDVDQLVACIESK | 471 | Q6P996 | |
| RQCEEVARALGKESL | 241 | P51570 | |
| LCGESEKEQIREDIL | 86 | P28161 | |
| GIELICEKDIDLAAQ | 846 | O60229 | |
| DIEAQERGVRCLLEK | 666 | P48449 | |
| IDCAGILKLRNSDIE | 531 | O95644 | |
| ELKTLCEEEEEGQGR | 216 | Q8N3D4 | |
| GALDAELKACRDQEE | 181 | Q8N1N4 | |
| EELLKRAGERSAVEC | 481 | Q86UK5 | |
| LKGVTCENREAVLDA | 311 | Q9Y4W2 | |
| LQDDVACDIIKIGSL | 136 | Q13601 | |
| CEQEKLPGQERLLEE | 321 | A6NI86 | |
| DVEIFCDILEAANKR | 171 | Q86UY5 | |
| CILKALADENEFVRD | 1781 | Q92616 | |
| QADLLRCQAKIEDLE | 526 | Q96N16 | |
| RDECGKAQAEVDRLL | 716 | O15083 | |
| EDLCKIGSERSLVLD | 251 | Q13422 | |
| NREVLKRELGLAECD | 551 | Q9ULW8 | |
| KETIEELRCVQAQEG | 421 | Q86VS8 | |
| GRLELKEDNIECLLS | 281 | Q96PQ7 | |
| EDGLCISDLVLDVRQ | 791 | P17301 | |
| AVDCVGILKLRNADV | 381 | O94916 | |
| AREKEEVVLRCGQEA | 311 | O95613 | |
| EVVLRCGQEAAELKE | 316 | O95613 | |
| VALEIDGLEEKLSQC | 11 | Q9P0B6 | |
| DGLEEKLSQCRRDLE | 16 | Q9P0B6 | |
| EAACQAVLELCRKEL | 246 | Q8TE96 | |
| QVEAQGEKIRDLEVC | 131 | Q8ND30 | |
| GEKIRDLEVCLEGHQ | 136 | Q8ND30 | |
| VGDLEDCLLNKVDLR | 6 | Q8N8X9 | |
| GCTAELVLQDLQRED | 3941 | Q5VST9 | |
| EDKAQILLDCGEDNI | 636 | P08648 | |
| EDVNKCIIALRDQDA | 516 | Q9UI47 | |
| GKESCDVVLLDENLL | 1966 | Q9Y2I7 | |
| DLVVECRDIVGNLTE | 666 | Q92896 | |
| AVKGDAAEVERCLAR | 41 | Q5VUR7 | |
| TESDVNKEGLECLRL | 901 | Q08462 | |
| CKALLDVLGIEVDAE | 376 | Q13535 | |
| GSKFCEEDIDQILLR | 1371 | Q3L8U1 | |
| DGAIKALCNRLVVVE | 96 | Q9ULT8 | |
| GIEKESDLCVLNLIR | 281 | Q8NFZ0 | |
| AELCVVLNDEKVEGV | 531 | Q8N9C0 | |
| NIIAQAKALCEVEEG | 1356 | Q4G0P3 | |
| CILIDENDNKIGAET | 21 | Q13907 | |
| CVEADDVEGKIRQII | 101 | O14929 | |
| FELEGLRCLVDKLES | 456 | Q9Y2K7 | |
| SLVIRGDKDEQAVLC | 61 | Q9BVC3 | |
| DACGQALDVNERLIK | 2106 | Q96BY6 | |
| IVDCIRAELQSIEEG | 581 | Q8WTW3 | |
| CVIALQEKDVDGLDR | 526 | P35221 | |
| SVQALIDACLEEDGK | 496 | Q8NE35 | |
| ELCRDFVEALKAVVG | 26 | Q86WU2 | |
| ILSCLEDEKIQTREG | 341 | Q9H0C8 | |
| GTAHLKLERLENECE | 796 | Q5T0F9 | |
| QLLACAGVEAERVVE | 651 | Q92771 | |
| RRLDLDIDGLQKENC | 586 | O43303 | |
| DGAQKKLRECESVLV | 306 | P60228 | |
| NLIEECEQAERLGAV | 126 | Q96HE7 | |
| ITQEVAAEVCREGLK | 781 | Q8TF61 | |
| CKIADFGLARVIEDN | 381 | P07948 | |
| IEKDAREFLDKQVCG | 731 | O15021 | |
| VCIDVGTDNIALLKD | 201 | P23368 | |
| QNEAALECLRKAEEL | 66 | P09913 | |
| EIAEILCNIGVKLSD | 776 | Q8N7U6 | |
| EQARGVLKCDITDLQ | 741 | Q14831 | |
| EEKNVLGSALLCIAE | 1706 | Q9H583 | |
| RNAEIIEVGEKNAAC | 1671 | Q05BV3 | |
| AKLEECVRSIQADGL | 156 | P24534 | |
| CGQSGILRELEEKAD | 901 | Q9Y3R0 | |
| DCKLRQKAIAEVDVG | 81 | P0CAP2 | |
| LILCVTKAREGSEED | 21 | P31944 | |
| AIVREDLLSAKVCDL | 136 | Q99590 | |
| ETVAECRVLQKLGAD | 201 | P00491 | |
| EEEVKGLRGQLEACQ | 106 | Q494R4 | |
| DAKQCLEIGRDTLRD | 46 | P36268 | |
| DLAARNVLICEGKLV | 826 | P09619 | |
| IAELLCKNDVTDGRA | 91 | P0DJD0 | |
| EVEKIALNLEGCALS | 406 | Q9NZT2 | |
| QQCIDKARDLLDAEL | 1561 | P42345 | |
| KDNVAREGCILDLSD | 221 | Q5VVY1 | |
| CLVILGDDLSRVNKE | 131 | P53609 | |
| EDIKLCREALDVLGA | 271 | Q92552 | |
| AKQSLDVLDLCEGDL | 421 | Q8IZ73 | |
| DVGGCKEQIEKLREV | 176 | P35998 | |
| QIEDEIKGCLDFLRT | 471 | P26639 | |
| ACRDVEKGELVAKEI | 71 | Q8TC12 | |
| LEVKALIQDIRDCSG | 21 | Q12981 | |
| GCQKLIEVDDERKLR | 11 | P62753 | |
| RAVDVVLDCFLAKDG | 31 | Q9BX59 | |
| LCEKAIEVGRENRED | 281 | P31948 | |
| EVLVDLFLKEGACDE | 176 | P78395 | |
| TEDCIALVLKGEADA | 396 | P02788 | |
| ELAELEDALRNLKCG | 151 | Q15628 | |
| LLIEGENCGEDALRE | 251 | Q8WXG1 | |
| KEEGEILASCELILQ | 1196 | A0AVI2 | |
| IDCAGILKLRNSDIE | 521 | Q14934 | |
| LVLKGDFDACEELIE | 216 | Q9UL63 | |
| ARQAGEVVCEAIKNE | 16 | P29218 | |
| EEDRIICEAHKVLGN | 141 | P10244 | |
| VLDANLCLKGEDLDS | 261 | Q96T51 | |
| LDLTACRQLKDEAIV | 171 | Q9H469 | |
| LDGELNLKIETELVC | 186 | O60921 | |
| ICIDKGLTDESEILR | 711 | Q8IV36 | |
| RSCLVEGDAKEEILQ | 341 | Q05209 | |
| KLEVCRLLLEQGAAV | 1046 | Q9HCD6 | |
| REELARDKCVVIGLQ | 561 | Q9Y2G9 | |
| TGKAVEDLCRIKQVD | 3816 | O75592 | |
| RAEEDEFIILACDGI | 231 | O75688 | |
| ELCLKEERFADAIIL | 581 | Q9NQW1 | |
| ERVDLEELIECATGK | 581 | Q8NEM2 | |
| ELQIFGLDCEEALIE | 11 | Q14181 | |
| IREVLTCKIEELGSE | 216 | Q14181 | |
| RVIGDQLEKLCDSLL | 121 | A6NNN8 | |
| RELIEIGCEDKTLAF | 226 | P40692 | |
| VIVKCGDDLRQELLA | 561 | Q9UBF8 | |
| RKKANEVDCIVLVGD | 196 | P21108 | |
| EVDCIVLVGDVNDRV | 201 | P21108 | |
| LEETKQGNLERECIE | 46 | P07225 | |
| ELIDRLACLSEEGNE | 206 | Q9Y2L1 | |
| VECVEIFQLLSGEKR | 76 | O60287 | |
| ELLKLRSAECIDEAA | 21 | Q8IYS1 | |
| EQARLGRCLDDVKEK | 296 | P12755 | |
| KEGRIDDLLRANCDL | 231 | Q86UE8 | |
| LVDRKCQLDVLDGEN | 91 | A7E2S9 | |
| KCGEAIRSLQEAEKL | 266 | Q5VW32 | |
| VEEVKELCDGLELEN | 361 | O75891 | |
| GEAERDCDNKKIRLE | 816 | P51825 | |
| IAKAIEVLLTLCGDD | 416 | Q8TCG1 | |
| AEGKRVCVIDAAVLL | 461 | Q13057 | |
| CVKQRLERGEDLEIN | 346 | Q7RTR0 | |
| GVELVVNVDCLRKLE | 1001 | Q9BXT8 | |
| QSRILDQKEDGCVVD | 1086 | Q99570 | |
| DQFLKICLAEDEGLL | 651 | Q7KZ85 | |
| CLELELGQSREELDK | 76 | Q5JTD0 | |
| CAVLEERKGELLQAL | 221 | Q9BYV2 | |
| RKLGLKVDEDCEECQ | 456 | Q8TCY9 | |
| NGEIDIRGEDTEICL | 1201 | A0JNW5 | |
| AEAGVALLENECEKR | 851 | Q8N2E2 | |
| ALLENECEKRIVEEG | 856 | Q8N2E2 | |
| QGCRKAVLNDIDEDL | 611 | A4D1E1 | |
| LKTDERGILQGDCAD | 71 | Q13360 | |
| ALLCKGRDQTLEALE | 511 | Q9ULX5 | |
| DEAAGLEADLECKQI | 141 | P49588 | |
| RVVLDKALTDCGELA | 1861 | Q13129 | |
| KDQVLLEGEAATLLC | 2591 | Q15772 | |
| DLLKLTRDDVIQICG | 356 | Q12800 | |
| LLDNVKCRGEESALL | 536 | Q8WTU2 | |
| LCKIGVLRVDDQIAI | 201 | Q15257 | |
| AANIDEKTLKREGVC | 236 | Q9GZZ9 | |
| LCRLEAQKAAGAAEE | 16 | Q6ZVD7 | |
| VNGVQSCKDLEDLLR | 106 | A6NJL1 | |
| QLKADLDELVAAECV | 931 | Q9P253 | |
| AQETCGLDRILEALK | 11 | Q9C0B7 | |
| DCAGILKLRNSDIEL | 536 | Q12968 | |
| EAAEIDCQDLEERLG | 1546 | P11277 | |
| AADKVVIEACDELGI | 566 | P31939 | |
| NEEIAIDCRLGLKEG | 1046 | O43151 | |
| LADERFKGDVACQVL | 1446 | Q8IUG5 | |
| ILCGAADEVLAVLKN | 131 | O75643 | |
| LERAEERAELSEGKC | 176 | P09493 | |
| ICEIDIVLNDGETRK | 11 | O75436 | |
| KDDDILLNLVGCENS | 186 | Q8N3Z6 | |
| GQKECDNALRELETV | 1361 | Q9Y4G6 | |
| REGELCSLLKENVSE | 416 | Q9P272 | |
| LAGVKIAEVDCTAER | 371 | Q8NBS9 | |
| LEIEAARILIGAAKC | 531 | Q5TAH2 | |
| LSKEELIAELQDCEG | 36 | O43175 | |
| GLLDLCRNTEEVEAI | 331 | Q9Y210 | |
| DGKVLEALQVLRCEL | 226 | Q9H7D7 | |
| GDACLDIDKLLANVV | 21 | Q4G0G5 | |
| GLQQAEERLKRDCID | 216 | Q5VYS8 | |
| DLRRIQDEKALCEGE | 406 | Q8IY18 | |
| QDEKALCEGEIIDKR | 411 | Q8IY18 | |
| RAILCNDGLVKRLEE | 141 | Q9NRD5 | |
| VELVCKLCVRQVEGE | 791 | O95185 | |
| KDFVVGVLDLCRDTE | 271 | Q9HCX4 | |
| GVLDLCRDTEEVEAI | 276 | Q9HCX4 | |
| FVGEVKRCEELERIL | 51 | Q9Y487 | |
| CANTEIIVKLSDGRE | 61 | P10145 | |
| CERQLRKGDEFVLKE | 146 | O60663 | |
| ENDLQDDGVKLLCEA | 961 | Q86W25 | |
| RGEVCNAVLAKDALV | 321 | O15146 | |
| RAVNELGEALAECKL | 1121 | Q14324 |